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Numerous computational techniques have been applied to identify the vital features of 
gene expression datasets in aiming to increase the efficiency of biomedical 
applications. The classification of microarray data samples is an important task to 
correctly recognise diseases by identifying small but clinically meaningful genes. 
However, identification of disease representative genes or biomarkers in high 
dimensional microarray gene-expression datasets remains a challenging task. This 
thesis investigates the viability of Pareto optimisation in identifying relevant subsets of 
biomarkers in high-dimensional microarray datasets. A robust Pareto Optimal based 
feature selection framework for biomarker discovery is then proposed.  
First, a two-stage feature selection approach using ensemble filter methods and Pareto 
Optimality is proposed. The integration of the multi-objective approach employing 
Pareto Optimality starts with well-known filter methods applied to various microarray 
gene-expression datasets. Although filter methods provide ranked lists of features, they 
do not give information about optimum subsets of features, which are namely genes in 
this study. To address this limitation, the Pareto Optimality is incorporated along with 
filter methods. The robustness of the proposed framework is successfully demonstrated 
on several well-known microarray gene expression datasets and it is shown to achieve 
comparable or up to 100% predictive accuracy with comparatively fewer features. 
Better performance results are obtained in comparison with other approaches, which 
are single-objective approaches. Furthermore, cross-validation and k-fold approaches 
are integrated into the framework, which can enhance the over-fitting problem and the 
gene selection process is subsequently more accurate under various conditions. 
Then the proposed framework is developed in several phases. The Sequential Forward 
Selection method (SFS) is first used to represent wrapper techniques, and the developed 
Pareto Optimality based framework is applied multiple times and tested on different 
data types. Given the nature of most real-life data, imbalanced classes are examined 
using the proposed framework. The classifier achieves high performance at a similar 
level of different cases using the proposed Pareto Optimal based feature selection 
framework, which has a novel structure for imbalanced classes. Comparable or better 
gene subset sizes are obtained using the proposed framework. Finally, handling missing 
data within the proposed framework is investigated and it is demonstrated that different 





1.1 Research Motivation  
Microarray datasets have been increasingly used during the last two decades, 
and this creates an intriguing challenge for machine learning and 
bioinformatics. Microarray data is comprised of gene expression information 
gained from tissue or cell samples. It uses gene expression values for disease 
diagnosis or the classification of specific types of tumour (Bolón-canedo et al., 
2014). Mostly, while there is a minimal number of samples (usually less than 
100) for training and testing, the number of features generally found in original 
data ranges between 6000 and 60,000, and hence a gene expression dataset is 
considered as a type of a big data (Bolón-Canedo, Sánchez-Maroño and Alonso-
Betanzos, 2015). Microarray technology provides biologists with a valuable 
tool for measuring thousands of gene expression levels in a single experiment 
(Saeys et al., 2007). The sheer amount of gene expressions obtained in various 
microarray data analyses can be used in classification tasks (Jirapech-Umpai 
and Aitken, 2005). 
It is difficult for machine learning methods to deal with high numbers of input 
features (Bolón-Canedo et al., 2013) and high dimensional big data often 
creates a problem for researchers when working with them (Khoshgoftaar et al., 
2013). Therefore, feature selection algorithms have become indispensable 
components of the learning process and face to many input features during the 
descriptive analysis of the research. However, the performance of feature 
selection methods can be adversely affected from high numbers of input features 
(e.g., Information Gain and ReliefF). In addition, the classification process can 
be conducted without feature selection and training and validation performances 
in terms of accuracy can be reasonably good. However, testing the performance 
of the classification model often far from meeting expectations, and many 
studies have shown that feature selection has a significant effect on efficiency 
of machine learning methods (Jirapech-Umpai and Aitken, 2005). It is 
reasonable to expect that having so many features with limited samples create a 
high likelihood of finding “false positives” in discovering relevant genes and in 
building reliable predictive models. While more features might be expected, at 
least theoretically, to provide more discriminatory ability, they, in reality, 
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contribute to a significant slow-down of the classifier training process and also 
result in overfitting the training data due to the presence of redundant features 
which impacts negatively on the learning process (Yu and Liu, 2004). Several 
studies have shown that microarray data often contain redundant genes that are 
irrelevant to accurately classify different classes of the microarray dataset 
(Bolón-canedo et al., 2014). 
Machine learning methods have been utilised to discover hidden structures in 
biological data and biomarkers. For this purpose, reducing dimensionality for 
the analysis of the data, selecting a subset of the features, classifying the data, 
clustering, and estimating new situations are the primary applications (Saeys et 
al., 2007). Most machine learning algorithms for feature selection demand a 
high number of samples to effectively produce less but relevant descriptors 
(Mandoiu and Zelikovsky, 2008; Wu et al., 2008; Bolón-Canedo and Alonso-
Betanzos, 2019). Therefore, feature selection methods as a common and 
efficient strategy, aim to decrease the number of dimensions of the dataset. In 
gene expression studies, gene selection is a de-facto method to identify the most 
relevant genes by deleting irrelevant and redundant genes (V. Bolon-Canedo et 
al., 2015). Feature selection refers mainly to gene selection, in such studies.  
Feature selection has been broadly studied in the literature, particularly for 
classification (Saeys et al., 2007; Sun et al., 2015; Bolón-Canedo and Alonso-
Betanzos, 2019). Recently, with the proliferation of high dimensional datasets, 
big data analysis has become a widely studied research area in engineering as 
well as other fields including the physical, biological and biomedical sciences 
(Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 2014). For instance, 
the analysis of microarray gene expressions is an important process in the 
biological sciences where thousands of genes simultaneously are expressed in 
relation to diseases. The information or knowledge obtained from microarray 
data is valuable and could be big and further analysis is required to be performed 
for subsequent prospective actions (Bolón-canedo et al., 2014; Veronica Bolon-
Canedo et al., 2015). One such action is the gene selection before the 
classification takes place. The robustness of feature selection is a crucial issue 
in classification and mostly obtained by the validation methods (Khoshgoftaar 
et al., 2013; Gerlein et al., 2016). Recent studies have shown that the efficiency 
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of the classification is highly affected by the feature selection methods that were 
used (Yang and Mao, 2011; Seijo-Pardo et al., 2015).  
In well-known low dimensional problems, the number of observations is much 
higher than the number of genes. This means that the dataset contains sufficient 
information for the training process in order to learn the distribution of patterns 
(Yang and Mao, 2011). Many existing pattern recognition algorithms can 
provide satisfactory results with this kind of low dimensional data. However, 
gene-expression datasets have high dimensionality and a small structure 
(HDSS) that has attracted considerable attention from the machine learning 
perspective (Yang et al., 2015). Higher numbers of features and low number of 
samples creates a considerable challenge for pattern recognition algorithms. 
This situation is called the “curse of dimensionality”  (Bellman, 1961) where 
the search space for a subset increases exponentially (Malley, Dasgupta and 
Moore, 2013). Thousands of features make it impossible to form the candidate 
solutions using an exhaustive search. Another problem is the small numbers of 
samples for the algorithms. These make the search even more challenging in 
establishing a subset of relevant features (Winkler, Affenzeller and Wagner, 
2007). 
In the analysis of biological data, selecting the subset of the identified problem-
related features (e.g. genes in microarrays) can be used for cancer treatment 
studies, biomarker discovery, drug discovery and similar research, so it is an 
essential and critical process. Nowadays, microarray datasets have become the 
most common source for the analysis of gene expression (Veronica Bolon-
Canedo et al., 2015). Microarray datasets have existed for two decades (Taub, 
Deleo and Thompson, 1983), and they contain huge amounts of biomarker 
information (Makałowski, Jakalski and Makałowska, 2014). Biomarker 
detection is a difficult problem, especially when the number of genes is 
significant, and thus the search space grows exponentially (Ahmed, Zhang and 
Peng, 2015). Biomarker selection is a challenging process due to the high 
dimensional nature of post-genomic data such as microarray gene expression 
(Uslan, 2015; Peng, Li and Liu, 2017). Subsequently, biological datasets 
contain many features, only a small group of them is associated with the 
problem (Saeys et al., 2007). Gene information is collected from many patients 
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especially cancer patients. Researchers collect it to compare with the data of 
healthy people whether to predict, diagnose, or monitor disease. Machine 
learning techniques became indispensable tools, and researchers are highly 
benefiting from many machine-learning methods to identify useful information 
from the massive amount of raw data they have.  Biomarkers are beneficial for 
each stage of patient care. (Michiels, Koscielny and Hill, 2005; Yang and Mao, 
2011; Bolon-Canedo et al., 2017). 
Therefore, it is of great importance to select a subset of representative 
biomarkers. The aims of the biomarker selection can be summarised as follows: 
(i) to reveal features associated with a problem identified in biological data such 
as genetic networks, structures and mechanisms, which are involved in the onset 
and progression of the disease, and (ii) to improve the accuracy and 
interpretability of the predictive model used to extract the features. 
However, small sample sizes and high numbers of features in biological data 
are the main difficulties encountered in these studies. Thus, many feature 
selection algorithms have been proposed to overcome these problems. The 
disadvantage of having many solution methods is that, when different selection 
methods are applied to the same dataset, different biomarkers (genes) or subsets 
of biomarkers may be selected. At the same time, the selection process must be 
independent of sample variation in the dataset (Alpaydin, 2010). The same 
feature selection algorithm can result in the selection of different features even 
when applied to two sets of data that are very similar to each other. In many 
related studies, it has been shown that feature selection and ranking are related 
to dataset variation and selection methods (Michiels, Koscielny and Hill, 2005; 
Yang and Mao, 2011). These studies show that it is unreliable to use only one 
learning set per feature or only one method for feature selection. 
Despite the expectation that a feature selection method would eliminate 
irrelevant variables resulting in good classification performance, classifiers 
often tackle the contradiction between bias and variance in datasets. The bias-
variance trade-off is an important concept to be considered during the design of 
the model. The bias indicates a degree of adaptation of the model to the training 
set, but this is not a measure of generalisation. However, variance represents the 
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variability in the model performance that occurs during the class prediction of 
data samples (Alpaydin, 2010). 
Feature selection, also called biomarker or gene selection in gene expression 
studies, can be utilised by applying the filter, wrapper or embedded approaches 
(Saeys et al., 2007). In filter methods, information-based evolution relies on the 
overall features of the training data and the gene selection is regarded as a pre-
processing stage which can be considered independently from the induction 
algorithm (Bolón-canedo et al., 2014). 
Existing studies show that it is unreliable to use only one learning set per feature, 
only one method for feature selection, and ranking for disease-associated genes. 
The current trend is based on ensemble methodologies to gain better results 
(Bolón-Canedo and Alonso-Betanzos, 2019). 
This continuing research trend tackles many challenges in microarray data. It 
shows the generic characteristic of big data even with the small sample sizes 
that present fundamental difficulties. Class imbalance, missing data, 
overlapping between classes, non-linearity, and such as genes extracted under 
different distributions (Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 
2015). Typically, microarray datasets have fewer than 100 samples, and 
thousands of features make the training process of a prediction model more 
laborious. Less information and more criteria for decisions aggravate the 
problem. In the literature, several studies show that most gene-expression values 
in a DNA(deoxyribonucleic acid) microarray experiment are not related to 
objective class so there is no benefit to classification accuracy (Hira and Gillies, 
2015). This type of information may cause a reduction in the performance of 
classifiers such as the C4.5 decision tree classifier as the decision tree method 
is faced with numerous redundant features that are completely unrelated with 
the response classes of the study. (Bolón-Canedo, Sánchez-Maroño and Alonso-
Betanzos, 2015). Likewise, instance-based learners such as the 𝑘-nearest 
neighbour (𝑘-NN) are strongly affected by redundant features. Higher numbers 
of irrelevant features exponentially increases  the demand for training instances 
to produce a predetermined level of accuracy performance (Alpaydin, 2010). 
The irrelevant features slow down the learning process of these methods and 
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decrease their performance (KaltenbachHans-Michael, 2013). Adding 
redundant features, even those related to the concept under research, rapidly 
decrease prediction performance. These circumstances create the necessity for 
minimising the negative effects by establishing a robust framework for the 
analysis. The robustness of the established framework often obtained using the 
validation approaches (e.g., cross-validation). Thus, the established framework 
avoids negative effects, such as the problem of overfitting. Furthermore, the 
models used must deal with classes that are imbalanced, and with samples 
extracted under different conditions in both training and test datasets, thus 
stimulating research into utilising the analysis of microarray data (Veronica 
Bolon-Canedo et al., 2015).  
This study aims to create a new framework combining a selection method, 
which is not influenced by sample variation in the dataset with the multi-
purpose optimisation Pareto Optimal (PO) approach. 
1.2 Rationale of the study 
Most of the existing related studies rely on an individual feature selection 
technique with single feature ranking. The singular evaluation provides a set of 
redundant attributes which often slow down the learning process and degrade 
the classification accuracy (Bolón-Canedo and Alonso-Betanzos, 2019). 
Important aspects to consider are class imbalanced datasets (Fernandez, Garcia 
and Herrera, 2011) and missing datasets. In imbalanced datasets, a majority 
class generally has a greater effect while selecting features. This challenge 
remains an open research issue in handling high dimensional datasets with 
noticeably imbalanced class distributions (Maldonado, Weber and Famili, 
2014). However, most of the techniques applied certain limitations and yield 
different subsets of attributes. Therefore, it is considered that there is still room 
for improvement in the feature selection process, especially in the big data era. 
Several types of feature selection methods perform a random selection process, 
where different feature subsets are selected in every run from the same dataset 
and all subsets are used in classification such as SVM (Maldonado, Weber and 
Famili, 2014) or K-means (Wu et al., 2008). In these cases, the results of 
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classification can be unstable, and considerable computational resources could 
be needed during the classification process. 
One of the challenging aspects of big data is missing data, where microarray 
datasets contain missing information about genes (Troyanskaya et al., 2001). 
The major research challenge here is how to fit the most suitable model 
induction algorithm for missing data. Current methods and approaches can only 
recover data according to other successful samples (Souto, Jaskowiak and 
Costa, 2015). Identifying the most valuable features is necessary for research in 
this area (Muresan et al., 2015). 
This research study, therefore, aims to address the aforementioned problems 
when handling big microarray data with the use of computational methods. The 
specific objectives of this research are discussed in the following section. 
1.3 Research Aim and Objectives 
This research aims to investigate the viability of Pareto optimisation in 
identifying relevant subsets of biomarkers in high-dimensional microarray 
datasets. The primary objectives are as follows: 
• To propose and develop a PO based predictive gene selection framework 
for biomarker discovery 
• Integrate different feature selection and cross-validation approaches 
• To handle the problem of imbalanced data distribution for gene selection 
within the proposed framework 
• To evaluate the contribution of different data imputation methods on the 
proposed framework performance when there are missing values in the 
data 
• To evaluate the classification and generalisation performance of the 
proposed framework on well-known microarray gene expression datasets    
1.4 Research Methodology 
Different microarray datasets are applied to test the unique subsets and 
robustness of the proposed framework. The framework contains multiple stages 
for multi-criteria decision cases. Its adjustable structure is analysed with 
different parameters and altered structures. 
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Given the nature of non-streaming data, the cross-validation method may be the 
solution to validate the dataset. Variations in the dataset are applied to prove the 
robustness of the model. When variables change, the PO-based framework is 
consistent in achieving a high level of accuracy. This consistency makes the 
framework more reliable, especially for further biological studies. The role of 
PO is to eliminate irrelevant and redundant features and to generate a common 
gene subset for each dataset. The gene selection performance is evaluated by 
classification. Relevant information about performance results is shown in 
tables. 
1.5 Research Scope 
This research focuses primarily on gene selection problems and is limited to 
microarray data case studies. Microarray datasets are suitable for the analysis of 
big data applications. The aim is to not only use common gene expression 
datasets but also to determine the applicability of PO on imbalanced and missing 
datasets. Besides, these datasets contain valuable information about various 
cancer diseases, which are used as case studies. 
Most of the imbalanced datasets have binary values, so the present research is 
limited to imbalanced binary classification problems. Two of comparison 
datasets contains multi-class samples. We applied one vs all classification to 
match up binary datasets classes as healthy vs all other disease classes.  
1.6 Contribution 
In this thesis, a generalised computational framework is proposed that could 
employ any feature selection method and classifier model to identify 
representative subsets of genes in high-dimensional gene expression datasets. 
The main contributions of this thesis are summarised as follows:   
1. A computational framework is developed based on Pareto Optimization 
for the purpose of identifying subsets of disease representative genes. 
PO based framework is designed to be independent of any feature 
selection methods and classifier models. The stability and robustness of 
the proposed system are validated using different feature selection 
methods. Due to its properties, such a framework can be easily adapted 
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with any feature selection method that may suffer from randomisation 
problems. 
2. The proposed PO based framework is applied to imbalanced datasets. 
The gene expression datasets due to its nature are very high dimensional 
datasets. The proposed framework has not only addressed the high 
dimensionality with the use of feature selection methods, but the issues 
related to the imbalanced datasets are also addressed with the utilization 
of multi-criteria approach that considers the imbalanced dataset as a 
number of balanced sub-datasets.   
3. The proposed PO based framework is applied to datasets having missing 
values. Real-world datasets commonly contain missing values and 
elimination of those values from datasets cause loss of information 
(Troyanskaya et al., 2001). Missing values is a common problem in gene 
expression datasets (Souto, Jaskowiak and Costa, 2015). Simply 
discarding samples having missing values might result in valuable 
information being lost (Silva and Perera, 2017). This study has also 
investigated how the proposed PO-based framework selects 
features/genes when missing values are replaced using well-known 
statistical imputation methods. The classification performance of the 
proposed method is assessed for each imputation method. Moreover, 
these imputation methods are compared to each other in order to identify 
which ones offer better results. 
1.7 Thesis Organisation 
Chapter 1, Introduction: This chapter introduces the problems of dealing with 
high dimensional data, shows the significance of feature selection, and outlines 
the research motivation, aim and contribution. An outline of the thesis structure 
is presented.  
Chapter 2, Literature Review: This chapter presents background information 
about feature selection with big data, followed by a review of studies of gene 
selection in microarray datasets. It then describes relevant studies, and the 
progress made on gene-expression data classification approaches used in 
bioinformatics and gene selection methods used to decrease dimensionality to 
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give for improvements in classification. It also discusses the main challenges 
involved such as the curse of dimensionality and overfitting. Finally, the PO 
method is discussed and the research methodology and the research hypothesis 
for the present investigation are derived from the findings of the literature 
review. 
Chapter 3, Materials and Methods: This chapter explains the methods applied 
and microarray datasets used. 
Chapter 4 An Aggregated Framework for Biomarker Discovery of Disease-
Related Genes: The improvements found in comparison with the literature for 
all datasets are presented. How the framework was implemented to overcome 
the challenges of dealing with high dimensional data is discussed. The 
evaluation metrics used to analyse and compare the effectiveness of supervised 
feature selection methods previously applied are considered. The Cancer 
datasets exploited in this research to evaluate the performance of proposed 
frameworks are also described. 
Chapter 5 Pareto-Optimal Feature Selection Framework for Imbalanced Data: 
This chapter discusses the challenges posed by imbalanced datasets and the 
shortcomings of existing imbalanced data approaches. The proposed PO-based 
framework for imbalanced datasets is introduced, which is constructed from the 
proposed first framework. Finally, the results of the application of the proposed 
framework compared to previous gene selection methods used in imbalanced 
data studies of the Central Nervous System (CNS), ovarian, and lymphoma are 
presented. 
Chapter 6 PO Feature Selection Framework Application for Imputation 
Methods Comparison: Identifies research gaps in the area of the gene selection 
and imputation methods for missing values data. Imputation methods are 
compared to explore their effects on feature selection in missing values. Finally, 
experimental results are presented to show the effectiveness of imputation 
methods with feature selection for the five cancer datasets utilised to investigate 
performance. 
Chapter 7 Conclusion and Future Work: This chapter presents a discussion of 
the application and evaluation of the proposed framework for the different data 
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set types. The potential contribution of the framework to feature selection with 
different data types is discussed in greater detail. This chapter also concludes 




2 LITERATURE REVIEW 
2.1 Introduction 
This chapter reviews previous studies of gene selection. The significance of the 
field is discussed first, followed by a review of dimensionality reduction. Then, 
a review of gene selection and PO is presented followed by a discussion of 
existing feature selection methods for gene subset selection and classification 
problems. As Pareto Optimisation forms an important element of the proposed 
a gene selection framework, a detailed section on Pareto optimality is presented. 
2.2 Biological Datasets 
Biological datasets can be grouped into sequencing and microarrays data. 
Strings are pure textual data. Microarrays are numerical expressions that show 
the expression level of genes (Wang, Miller and Clarke, 2008). 
2.2.1 Sequencing Data 
DNA (Deoxyribonucleic acid) is a nucleic acid that contains the genetic 
information necessary for the biological functions of living creatures (Figure 
2-1). DNA particles (genes) are responsible for making proteins that are the 
basic building blocks for the living cell (Chuang et al., 2011). Genes that act as 
templates for protein production turn into RNA (Ribonucleic acid) sequences 
with properties similar to DNA. RNA sequences allow the formation of protein 
sequences (Schnattinger et al., 2013). 
DNA is the most basic text-based biological sequence that carries genetic 
information and has an alphabet with 4 letters (A, C, G, T). Words of the desired 
length can be produced with these letters, which are called Adenine, Cytosine, 
Guanine and Thymine (Veronica Bolon-Canedo et al., 2015). Researchers can 
encode enough words with this 4-letter DNA alphabet, just like the words 
created with two letters (dot and dash) in the same Morse alphabet and 2 letters 




Figure 2-1 Illustration of the DNA structure (genome.gov, 2020) 
 
2.2.2 Microarrays 
Genes, which are a sequence of DNA, transform first into RNA and then into 
protein and take part in all biological functions in the living cell. Each gene has 
different roles in biological life functions. If a researcher wants to find out which 
genes are involved in the biological events of a cell, they can make a decision 
by looking at the amount of proteins that are products of that gene in the cell. 
This process can be defined as gene expression which is the exact indicator of 
protein level of the cell. The frequency with which a gene is transformed into 
DNA→RNA→Protein is referred to as the expression level of that gene. The 
increase (up) of the expression level is interpreted as the activation of a gene, 
and the decrease (down) as the suppression of that gene (Bolón-Canedo, 
Sánchez-Maroño and Alonso-Betanzos, 2016). 
The expression level of genes can vary from cell to cell. Even for a particular 
cell type, the expression of a gene can vary depending on internal and external 
factors. For example, a gene that is highly expressed in a muscle cell may not 
be expressed at all in a liver cell. On the other hand, it happens that genes can 
be differentially expressed in the same cell when the internal and external 
factors are changed  (Ochs, Casagrande and Davuluri, 2010). For example, a 
normally under-expressed gene may be more expressed during cell division. 
The level of gene expression may vary according to environmental factors other 
than the internal factors of an organism. For example, a gene that is expressed 
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at the usual level in a plant can be expressed more or less based on the adaptation 
of the plant to the environment in times of drought. 
Microarray technology is used to determine the expression level of genes. With 
the application of the microarray technique, changes in the expression levels of 
thousands of genes can be detected simultaneously. The opportunity to compare 
many genes at the same time has enabled this technique to be used widely for 
different purposes (V. Bolon-Canedo et al., 2015). 
Generating gene expression data with microarray technology consists of many 
processes. The process of data creation is beyond the scope of this thesis. 
Therefore, the data used in this study are microarray data ready for analysis past 
all wet laboratory, image processing and quality evaluation processes. The data 
used is in a matrix format, where each row represents a gene, each column a 
sample. 
2.3 Bioinformatics 
The proliferation of data produced by systems biology has required extensive 
attention to sophisticated machine-learning tools and techniques, and this field 
is often described as bioinformatics  (Cesario and Marcus, 2011). Nowadays,  
numerous biological datasets are publicly available (Williams et al., 2010). 
Over the previous decade, databases have doubled in size every 15 month 
(Bolón-canedo et al., 2014). The doubling period has now dramatically 
decreased and enormous amounts of data are being created. 
Because of this growth in data, computational approaches to process and 
analyse large datasets have become essential for biological studies (Bolón-
Canedo et al., 2013). Recent advancements of computational power allow the 
efficient analysis of large quantities of data and the discovery of thoroughly 
complex structures in nature. “Bioinformatics, is often defined as the 
application of computational techniques to understand and organise the 
information associated with biological macromolecules” (Luscombe, 
Greenbaum and Gerstein, 2001). Bioinformatics has three main purposes. 
Firstly, it allows enormous volumes of data to be organised so that new entries 
can be added systematically. Secondly, tools and resources can be developed 
which support the analysis of data. Thirdly, to apply these tools on the 
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aforementioned data and discover biologically meaningful information  
(Luscombe, Greenbaum and Gerstein, 2001). 
Bioinformatics is a vital area of application in understanding biomarker 
detection; for example, in determining disease-associated genes (Mount, 2004). 
A systematic approach should be used to improve the effectiveness of 
biomarkers in medical usage  in the diagnostic and therapeutic environment 
(Eisenhaber, 2008).  
Bioinformatics tools are necessary for drug development and have become more 
productive owing to their systematic approach for the elucidation of disease-
associated genes and cancer drugs as well as the investigation of defective 
proteins as targets for drug discovery (Alpaydin, 2010). 
One of the sources of bioinformatics is gene expression datasets. Generally, 
they contain a large number of features, i.e. high dimensionality, a low amount 
of samples, i.e. a small dataset size. In medical studies, researchers extensively 
study gene expression datasets for analysing cancer-related cell lines and 
observing differentiation in them. (Luscombe, Greenbaum and Gerstein, 2001). 
Research in cancer biology has been significantly progressed due to the use of 
experimental methodologies and the revolution in genomics and bioinformatics 
that has produced enormous amounts of biological data (Niu et al., 2017) . One 
problem encountered is the conceptual frameworks used to organise high-
dimensional microarray datasets in such a way that more progress can be made 
in the understanding of diseases (Ochs, Casagrande and Davuluri, 2010). It is 
clear that research studies in bioinformatics can incorporate experimental 
results in wet laboratories through computational analysis and modelling. These 
studies can provide valuable insights into understanding the cause of diseases 
and help design novel and innovative therapeutic procedures. 
2.4 Feature Selection  
In recent years, owing to the internet and increased digital data storage 
capacities, many of high dimensional datasets have become publicly available. 
In this situation, it is a challenging for machine learning methods to be able to 
deal with high dimensional datasets (Mahajan, Abhishek and Singh, 2016). At 
present, the dimensionality of any archive datasets is significantly increased, 
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and different repositories store this data. The methods used for reducing the 
number of dimensions are essential in improving the efficiency of the 
computational models in order to tackle the issue of the high numbers of input 
features. (Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 2016).  
The task of dimensionality reduction is to identify a function 𝐹: ℝ𝑑 → ℝ𝑘 , to 
reduce the number of features in the dataset from 𝑑 to 𝑘, which suffer minimal 
accuracy loss when machine-learning models are applied.   Dimensionality 
reduction methods usually exploit the two concepts of feature selection and 
feature extraction, each of which has its own merits (Zhao and Liu, 2011). 
Feature extraction methods accomplish a reduction in dimensions of data from 
the initial set of features. Feature extraction combines the primary variables in 
order to generate less number of variables. Then, a new set of features that are 
representative of the dataset yielding more learning performance are created. 
Various real world applications such as  signal processing (Silvério Lopes and 
Magalh, 2011), image analysis (Samiappan, Prasad and Bruce, 2013) and 
information retrieval (Li, Li and Liu, 2017) mostly prefer this type of 
dimensionality reduction approach. In these cases, the interpretation is not as 
essential as the accurateness of the computational model. Widely used 
approaches for reducing the dimensionality are principal components analysis 
(PCA) (Moreau and Tranchevent, 2012) and linear discriminant analysis (Saeys 
et al., 2007). 
On the other hand, feature selection involves a process of finding a subset 
containing k features with the most information relevant to the problem defined 
in 𝑑 dimensional data. In this way, irrelevant and redundant features are 
removed from the subset   (Kira and Rendell, 1992; Guyon et al., 2006). This 
strategy widely is used in data mining applications, such as genetics analysis 
(Mooney and Wilmot, 2015), sensor data processing(García-Laencina, Sancho-
Gómez and Figueiras-Vidal, 2010) and text mining (Steenhoff et al., 2012). 
Consequently, feature selection retains the existing attributes that are essential 
for predictive models and extract useful knowledge (Bolón-Canedo, Sánchez-
Maroño and Alonso-Betanzos, 2015). 
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There are many problems encountered with very high dimensional data such as  
biological data sets where machine-learning methods are used for analysing 
these datasets and discovering hidden patterns of identifying useful correlations 
(Nilsson, 2007). However, applying machine learning on these large and high-
dimensional datasets is computationally prohibitive and requires powerful and 
expensive computing facilities. Also, ill-defined features can affect the 
performance of the employed machine learning methods (Hira and Gillies, 
2015). Therefore, the process of selecting smaller feature subsets is one of the 
most critical steps. Data can only be analysed after noise is removed. 
The most important aspects of dimensionality reduction are summarised below 
as a process before the analysis of the data (Alpaydin, 2010): 
a. Most learning algorithms depend on feature size (k) and the number of 
samples (N). Therefore, to improve efficiency, it is necessary to reduce 
the number of feature number. This will reduce the complexity of the 
inference algorithm. It also may help to reduce costs while limiting 
memory requirements. 
b. When irrelevant data is discarded, it will reduce the amount of time 
required for processing it. 
c. Learning algorithms used with small datasets are less influenced by 
specific factors such as noise and contraindication.  In this case, simpler 
models are more reliable. 
d. If the dataset is explained with fewer variables, it will be easier to extract 
the information because the production process is better understood. 
e. When data is visualised in several dimensions without losing 
information, a visual analysis of the structure of and outliers in the data 
will be possible. 
The process of feature selection mainly involves the identification of the most  
relevant features and the removal of redundant and irrelevant features to create 
a subset (Maldonado, Weber and Famili, 2014). The first benefit of feature 
selection is that it characterises the given problem more accurately and hence 
minimises the error rate. Without feature selection, ill-defined features can 
negatively affect the accuracy of classification of big datasets (Abdi, Hosseini 
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and Rezghi, 2012). (Yu and Liu, 2004) advised that additional effort is required 
to investigate the methods used on genomic microarray data in order to identify 
more informative genes and how few variables affect the performance in gene 
selection. Gene selection remains an open research area and every year the 
number of publications in those area increases (Bolón-Canedo and Alonso-
Betanzos, 2019). If optimal feature are chosen, a better understanding of the 
underlying problem and more accurate representations of aggregated data can 
be achieved (Chuang et al., 2011).  In bioinformatics, which is the area of focus 
of this research, feature selection is referred to as gene selection. The central 
argument for gene selection is that a limited subset of disease-associated genes 
are required in order to identify reliable biomarkers. The following objectives 
are pursued when looking for a proper subset of representative genes: 
2.4.1 Overfitting 
When the dataset is small and has a large number of features, such as the 
microarray gene expression datasets, the analysis of the dataset can be highly 
dependent on samples of the training dataset (Wang, Miller and Clarke, 2008). 
In such a case, the features are not properly selected, classifier learns many 
irrelevant patterns than the relevant ones, and in turn, classifiers might lack a 
generalization capability and provide very poor testing performances. Many 
efforts have been made on analysing the problem of overfitting (Hawkins, 2004) 
and mitigating its effect on the prediction performance of a classifier 
(Subramanian and Simon, 2013). 
2.4.2 Curse of dimensionality 
The concept of curse of dimensionality states to a number of issues that might 
arise during the organization and analysis of the high-dimensional data 
(Bellman, 1961). One such issue is that the available number of features far 
exceed the number of samples. The processing of the data usually relies on 
identifying parts of data where samples form groups with similar attributes. 
However, as the number of samples are often sparse and dissimilar from each 
other in high-dimensional data, data analysis approaches become inefficient and 
suffers from establishing the required computational model. A symbolic rule is 
that there should be at least five samples having meaningful values for each of 
the variables (Dash and Misra, 2017). Classifier performance often increase 
32 
 
when sufficient number of samples are available which are related to a good 
representative number of features. 
However, microarray experiments often lack the availability of sufficient 
amount of samples while the number of genes is naturally very large. It is often 
the case in microarray experiments that the number of probes representing the 














Figure 2-2 Curse of dimensionality (Haury, 2013) 
Prediction models are frequently used for gene expression datasets to develop 
rules that can be applied to accurately classify the results for patients based on 
their characteristics. Creating microarray datasets are, however, costly to 
process (Haury, 2013). Such models represent an appropriate tool in the 
diagnostic process as they provide clinicians with estimates of possibility that 


















2.4.3 Class Imbalance 
The nature of most biomedical datasets is to be imbalanced. For example, there 
may be more cancer cases than control samples (Shipp et al., 2002). Therefore, 
applying feature selection to imbalanced datasets needs further study since the 
features selected may be more representative for the majority class (Fernandez, 
Garcia and Herrera, 2011). The multi-criteria approach will explore tackling this 
issue of feature selection from imbalanced datasets. Feature selection from 
high-dimensional imbalanced datasets will be transformed into feature selection 
from different relatively small classification sample balanced datasets. 
Besides, this skewed class distribution has been found to cause training 
problems. Imbalanced sample proportion makes it harder to classify rare or 
minority classes because of training chance is much lower than majority cases. 
These minority or rare cases are with usually be cancer samples, so that it is 
crucial to classify them correctly. Commonly held is learning tendency of 
prediction models is upon majority class. From many data-level several 
approaches, most of the studies frequently used such as under-sampling, over-
sampling. These type of methods causes the loss of valuable data or over-rated 
results because of virtually created samples. Instead of missing the originality 
of the data, this study proposes an approach that can equalise the level of class 
learning and preserve existing data.  
2.4.4 Increase interpretability  
An interpretable computational model is much easier to understand for humans 
as compared to ones, which are uninterpretable. Gene selection undoubtedly 
prevents the complexity of the computational model and ease the difficulty in 
interpretation. Furthermore, the subset of selected genes can be different from 
one model to another. Prediction performance of case studies such as the cancer 
related microarray datasets are often accurate and efficient when appropriate 
subset of genes was extracted. The subset of selected genes can further be 




Accepting infinite computational power, in theory no doubt that the optimal set 
of genes could be selected (Hastie, Tibshirani and Friedman, 2009; Hira and 
Gillies, 2015; Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 2016),  
However, testing each possible subset among all numerous gene subset options 
is not possible in practice. In such a case, processing necessity of the selection 
of genes procedure can only happen in nondeterministic polynomial time. Thus, 
finding a solution for feature selection on microarray datasets become 
unattainable(Morán-Fernández, Bolón-Canedo and Alonso-Betanzos, 2017). 
Simplification techniques are inevitably required for establishing good 
interpretable computational models. Various feature selection methods are 
investigated in terms of how they rank genes efficiently and accurately. Each 
gene is assigned with a score showing its significance. Then these genes are 
ordered based on their significance scores. The ranking order for gene 
significance scores is set from highest to lowest. Then the list of scores can be 
limited according to threshold values to create a suitable subset of genes. There 
are three types of feature selection methods familiar in the literature are filter, 
wrapper and embedded methods(Saeys et al., 2007). Related algorithms utilised 
for gene selection are listed below for these groups. Finally, the PO method is 
introduced which is used intensively in of the core of this dissertation. 
2.4.5 Ensemble Feature Selection 
Ensemble feature selection combines various techniques by creating an 
ensemble learning from values of, for example, average, median, minimum, and 
maximum  (Deb and Raji Reddy, 2003; Niijima and Kuhara, 2006; Uncu et al., 
2007; Handl, Kell and Knowles, 2007; Dinu and Popescu, 2008; Soto et al., 
2009; Yang and Mao, 2010; Lee, Jung and Shatkay, 2010; Ting, Lin and Huang, 
2010; Chuang et al., 2011; Luo et al., 2011; Sabzevari and Abdullah, 2011). 
Furthermore, more complex models include ‘rank distance categorization’ 
(Dinu and Popescu, 2008), and ‘resampling and permutation feature 
importance’ (Yang and Mao, 2010) that downgrade the problem into a single-
objective optimisation problem. 
The performance of selected features can be calculated according to single or 
multiple objectives. In recent years, multi-purpose optimisation methods have 
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also been used for selection in bioinformatics studies (Moosa et al., 2016). 
Often, two-objectives functions have been used in evaluating the performance 
of feature subclasses (Zitzler and Thiele, 1999). The first goal is the success in 
classification. If a subset correctly classifies the classes of the targeted classes 
such as patient, then this is a representative subset, and the features selected by 
the method can be said to be related to the disease. The second objective is to 
optimise the size or model cost of the subset of features. In many studies, one 
of the aims of researchers has been to minimise error or maximise accuracy. 
Other goals are to reduce the number of features and the cost of the model 
simultaneously (Deb and Raji Reddy, 2003; Sabzevari and Abdullah, 2011). As 
an alternative to reduce single objective only, this study proposes a technique 
widespread in operations research, which is the PO approach, in a framework, 
applied to the selection of the subsets of features. 
2.4.6 Feature Selection Methods 
Despite advances in the field of gene selection, immense challenges remain for 
gene-expression analysis where data comprise information about tens of 
thousands of genes(Li, Li and Yin, 2016). As described in Section 2.4.2, this is 
often referred to as the ‘curse of dimensionality’. Moreover, high-dimensional 
data frequently includes numerous redundant and irrelevant genes. A relevant 
gene may be strongly correlated to another gene so in the presence of correlated 
gene it became redundant. Both experimental evidence and theoretical analysis 
show that data on redundant and irrelevant genes clearly affect the accuracy and 
speed of learning algorithms and thus it is advised that this data should be 
removed (Saeys et al., 2007; Anaissi and Kennedy, 2011; Bolón-Canedo, 
Sánchez-Maroño and Alonso-Betanzos, 2012; Hasnat, 2016). Feature selection 
techniques can be categorised as either individual evaluation methods or subset 
evaluation methods (Yu and Liu, 2004). The evaluation considers distinct 
features by assigning to them weights according to their degree of relevance. 
This is also known as feature ranking. Techniques of subset evaluation look for 
the smallest subset of genes that fulfil some measure of importance and are able 
to eliminate redundant genes as well as irrelevant ones. However, many of the 
current heuristic search approaches used for the subset evaluation. One 
particular method for these approaches for feature selection is the SFS. SFS 
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enables a significant amount of decrease in the search space. However, the 
search space is still hard to be processed in a reasonable time especially for 
microarray experiments where the number of genes is huge in amount. Thus, 
there is a need to consider a different framework for gene selection which 
prevents the gene redundancy and evaluates genes that are highly relevant (Yu 
and Liu, 2004).  
The three main approaches to feature selection are filter, wrapper, and 
embedded feature selection methods (Saeys et al., 2007). These methods are 
discussed in the following sections. 
2.4.6.1 Filter Methods 
Filter approaches are based on the general characteristics of training data and 
are used as a pre-processing step with the independence of the induction 
algorithm. The first merit of these methods is their low computational cost and 
good generalisation ability (Bolón-Canedo, Sánchez-Maroño and Alonso-
Betanzos, 2016). Also, their execution is faster than wrapper and embedded 
methods. However, they are prone to select large subsets (Saeys et al., 2007). 
Filter methods include the t-test (Chen et al., 2007), entropy (Nguyen et al., 
2015), Bhattacharyya (Haury, 2013), ROC (Nguyen et al., 2015), and Wilcoxon 
(Haury, 2013; Nguyen et al., 2015) tests. Fisher's ratio and Relief (Yang and 
Mao, 2010), and correlation-based feature selection (CFS) (Chuang et al., 2011) 
are used in the post-genome domain due to their simplicity and speed. 
These methods aim to achieve a possible subset that gives the highest score 
according to in limits of the technique itself. In these approaches, genes are often 
ranked in such a way that is appropriate for the research purpose, such as 
predictive success, correlation with class label, and so on. However, filter 
methods are independent of the estimation model selected and are not 
susceptible to any estimation model at this time. Filter methods are often 
counted as univariate methods and do not account for associations between 
features (Saeys et al., 2007).  
In the filter approach rather than the processing the search space, variables are 
selected based on the statics happen to be in the data. Filter methods are initially 
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preferred for microarray datasets as the feature selection method owing to the 
fact that they are highly efficient (Moosa et al., 2016). 
2.4.6.2 Wrapper Methods 
This type of methods processes the whole search space. The criteria function 
decides the variables to be kept or eliminated during the process in order to 
maximize relevancy of features. In a wrapper technique, one may use a loss 
function 𝑗 and any type of predictor 𝑔. The first proposed version of a wrapper 
method was sequential forward selection, which works by adding features to the 
subset one by one. The next version is called sequential backward elimination 
starts with the whole set of features and removes features successively. 
Several selection criteria can be used in these algorithms. The final subset size 
can also be selected by estimating prediction success with cross-validation. 
Wrappers can be considered to be feature-ranking techniques, which return 
nested subsets of variables of pre-defined sizes.  
Wrappers consist of a learning algorithm and run a prediction algorithm to 
identify the relative usefulness of subsets of variables. This communication with 
the classifier tends to yield higher accuracy than filters. 
Wrapper methods such as SNR, SVM-RFE (Niijima and Kuhara, 2006; Luo et 
al., 2011), simulated annealing (Lee, Jung and Shatkay, 2010) and genetic 
algorithms (Chuang et al., 2011) are methods that depend on the classifier 
selected. These methods use the success of the chosen classifier as an evaluation 
constraint in determining the most essential features. Wrapper methods can 
conduct forward or backward selection. In forward selection, each element is 
tested individually while the subset is empty to start with. In a forward selection 
method, new features are added to the subset according to the objective at each 
step, and the number of elements in the cluster thus increases. 
On the other hand, in a sequential backward selection method, a feature is 
removed in each step and the number of elements is thus reduced. In both cases, 
the stopping criterion may be an initial k-feature, or selection may continue until 
there is no additional reduction in error (Alpaydin, 2010). A significant 
disadvantage of such methods is the high computational cost incurred due to the 
need for classifier training and evaluation for each feature subset. When a high-
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dimensional space data analysis is required, the filter approach appears to be the 
best alternative in terms of reducing computational cost (Uncu et al., 2007). 
Embedded approaches are the third type of technique used for in feature 
selection, where filter and wrapper methods are combined. Correlation-based 
feature selection and Taguchi-genetic algorithm methods (Chuang et al., 2011) 
or correlation coefficients and K-nearest neighbours (kNN) (Uncu et al., 2007) 
are examples. 
A good example that can be suggested to be used as a wrapper method is the 
sequential forward selection method. Sequential forward selection (SFS) starts 
from an empty subset and adds features sequentially without any backward step 
until no more improvement can be achieved (Whitney, 1971) or when a stopping 
criterion is reached  (Pohjalainen, Räsänen and Kadioglu, 2015). This approach 
is well known and widely used in practice. Many similar methods have been 
proposed. For instance, sequential floating forward selection (SFFS) is 
performed in backward steps while the objective function increases (Pudil, 
Novovicova and Kittler, 1994) , random subset feature selection (RSFS) 
randomly adds features from subgroups to a chosen subset (Ho, 1998). SFFS 
provides a greedier and more flexible search of the dataset, and so checks more 
subsets. However, Reunanen (Reunanen, 2003) reported that the SFFS 
algorithm is computationally intensive and more prone to overfitting than SFS. 
It has been found in a recent comparative study that SFFS results in sizeable 
search space but fails to determine to a robust feature subset, performing worse 
than SFS (Pohjalainen, Räsänen and Kadioglu, 2015). RSFS can reduce the 
local optima problem and provide more diversity. Though, it relies on random 
values so it may over-fit to noisy data and may give different subsets every time. 
Furthermore, Saeys et al. (Saeys et al., 2007) cite the use of simulated annealing, 
probabilistic hill-climbing and genetic algorithms to overcome the local optima 
issue based on randomised search. These optimisation techniques make the 
algorithms less prone to local optima and take into account feature 
dependencies. On the other hand, randomised wrapper solutions contain similar 
disadvantages, being more computationally intensive and suffering from a 
higher risk of overfitting than deterministic algorithms. SFS is selected as the 
representative wrapper method due to its wide usage and simplicity. 
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Sequential forward selection is straightforward, and it stops searching when the 
highest value of an objective function is reached. However, this could be due to 
local optima in the dataset, but the SFS cannot continue to explore further (Uncu 
et al., 2007).  
For SFS, the objective function 𝐻(𝑆, 𝐷, 𝐶) = 𝑐 is used to find the best possible 
subset 𝑆 of features from the whole dataset, where 𝐷 denotes the dataset used, 
𝐶 denotes the classification model, c is the criterion function indicating the 
overall classification performance. SFS starts from an empty dataset, which is 
sequentially updated by including in each iteration the feature 𝑔, which results 
in the maximal score 𝐻(𝑆, 𝐷, 𝐶). Therefore, the feature set of size = 𝑓 is given 
by (Pohjalainen, Räsänen and Kadioglu, 2015) 
𝑆 = 𝑆𝑓−1 ∪ 𝑎𝑟𝑔𝑚𝑎𝑥 𝐻(𝑆𝑓−1 ∪ 𝑔, 𝐷, 𝐶)   Equation 2-1 
where g is the feature in the feature set, f. 
2.4.6.3 Embedded Methods 
This kind of method performs feature selection during the training stage and the 
method chosen is usually specific to a defined learning machine (Bonilla-Huerta 
et al., 2016). Consequently, the search for an feature subset is integrated into 
classifier structure(Li, Meng and Ni, 2008). These methods can identify 
dependencies at lower computational cost than wrappers. However, they are not 
suitable for generalisation (Haury, Gestraud and Vert, 2011)s, and commonly 
they are not preferred in the bioinformatics domain, and therefore are not used 
in the proposed framework. 
2.5 Pareto Optimal (PO) 
Given comparable empirical error, it can be said simpler models are more likely 
to generalise as compared to models that are relatively complex. Inspired from 
the principle of Ockham's razor, models would be better when designed more 
straightforward with less number of features (Alpaydin, 2010). 
In the real world, problems can involve various conflicting objectives. Thus, the 
search for solutions to real-life issues can yield multiple options. These options 
emerge when various criteria are considered at once. Common gene selection 
objectives are listed as follows (Sabzevari and Abdullah, 2011): 
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• enhancing the prediction performance of classification models; 
• organising less complicated models in terms of the computational 
resources required and, as a result, providing quicker and more 
cost-effective modelling; and where 
• the purpose is a better understanding of underlying gene-
expression data gained by eliminating irrelevant genes and 
building a more comprehensive dataset. 
PO has been applied to various problems such as public transportation (Prakash 
et al., 2008), sorting/scheduling (Kacem, Hammadi and Borne, 2002; 
Tavakkoli-Moghaddam, Azarkish and Sadeghnejad-Barkousaraie, 2011) and 
vehicle routing (Jie and Gao, 2010). In recent decades, the PO approach has 
been applied to biological features such as genes, biomarkers, and subset 
selection, and has been successful in selecting the best subclasses from 
evaluations of the classification performance of many gene subclasses (Fleury 
et al., 2002; Deb and Raji Reddy, 2003; Chen et al., 2007; Soto et al., 2009; 
Ting, Lin and Huang, 2010; Sabzevari and Abdullah, 2011). One of the earlier 
studies used three objective functions of mean slope, slope deviation and valid 
trajectories to filter genes (Fleury et al., 2002). In another study, two- and three-
objective feature selection was performed, taking into account univariate 
grading constraints such as fold-change, p-value, and selection frequency (Chen 
et al., 2007). However, the characteristic feature of these studies is that the genes 
selected were not ranked according to their importance. The Ranking is one of 
the critical outputs of biomarker selection. 
Local learners that use different subsets of data have been created for feature 
selection to avoid dependency on the diversity of dataset. PO approach is a 
multi-criteria decision-making method that can conduct feature selection by 
taking into account the rating values produced by local learners.  The vectors 
created using multiple training sets are used as objective values in the present 
study. 
Feature selection depends on the diversity of the data set, and the difference of 
the data set variations affects the sorting of the features. Because ranking 
methods sort them before selecting features, they choose a subset according to 
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their scores. Besides, ranking methods as local learners, use altered samples of 
subgroups, they create a different order of importance for features. 
Multi-criteria decision methods choose the best solution or most dominant 
solution sets between the conflicting objectives of real-life problems (Zitzler 
and Thiele, 1999). Three main multi-objective decision procedures can be found 
in the literature (Sabzevari and Abdullah, 2011) : aggregation-based strategy, 
PO-based and non PO-based strategies such as lexicographical methods, and 
PO-based approaches. Aggregation-based strategy is the widely used approach 
from three of them for multi-criteria oriented models. This consists of 
transforming multiple objectives into a single purpose by converting them into 
a complex scalar function. Thus, the multi-criteria characteristics of the target 
are abolished. The approach is straightforward and remarkably easy to use. 
However, it has quite prominent weaknesses, such as predetermining the trade-
off between objectives without relying on data content. This independence of 
target and trade-off leads to the need for intervention according to the intuition 
of the user, the combining of different units of measurements in one equation 
and, more importantly, the mixing of incommensurable criteria (Sabzevari and 
Abdullah, 2011). These drawbacks do not exist when Pareto-based approaches 
are used. 
However, the lexicographical approach can be used to classify different non-
comparable objectives utilising ad-hoc parameters determined by an 
aggregation-based method, it is less desirable as it providing only a single 
solution to the decision-maker (Sabzevari and Abdullah, 2011)  
On the other hand, each objective vector has a set of all elements, and accepts 
as equivalent value before comparison. The user exerts no influence in 
predetermining any trade-off or assigning priority to objectives in the PO. The 
decision-maker receives information on all statistically essential features when 
a Pareto optimal solution is chosen. The PO gives a meaningful set of possible 
features which can be analysed further by experts (Zitzler and Thiele, 1999; 
Sabzevari and Abdullah, 2011). 
Sabzevari and Abdullah (2011) narrowed down multi-objective feature 
selection methods to those that are proposed for gene expression datasets. There 
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are three different approaches (Aggregation, Lexicographical and Pareto) that 
can meet multi-objective perspective. Of these, only PO retains solutions as 
multi-objective outcomes. 
In bioinformatics, the expected benefit of discovering disease-related genes is 
to provide an advantage to molecular biologists in prioritising small numbers of 
meaningful genes from the thousands of genes in datasets. PO retains all 
objective-associated features and eliminates all redundant and irrelevant genes 
without user interaction. This is came from main idea from PO, which is “when 
no one can be made better off without making someone else worse off” 
(Pardalos and Du, 2008). Gene-expression data contains vital information, 
which can be gained by various methods, and there may be differences in each 
sample. Therefore, a molecular biologist should take the final decision 
concerning each potential disease-related gene. Ultimately, PO retains all 
potential disease-related genes, which is a more suitable objective than only 
providing a minimum subset. If PO discovers even one gene in one of the local 
training sets, it may help in further studies related to the diagnosis of diseases. 
2.6 Conclusion 
The computational models constructed on gene expression datasets often have 
a large number of genes and a smaller number of samples. As the models 
encounter difficulties in processing high dimensionality of the microarray data, 
feature selection methods were widely used to overcome such difficulties. 
However, selected genes may differ from one feature selection method to 
another even though the gene expression dataset remains the same. Therefore, 
depending on one feature selection method solely for a computational model 
may miss a feature having a more discrimination affect. Moreover, as each 
feature selection method may have some pros and cons in their own merit, it 
may also be hard to choose the appropriate feature selection approach for the 
computation model. Thus, it is considered that one possible approach that could 
be used to overcome such limitations is the use of ensemble methods. As 
compared to use of one method only, ensemble approach might provide more 
opportunities for finding better set of variables. The multi-objective decision-
making method, Pareto Optimality, is adopted as the basis of the proposed gene 
selection framework PO and is extensively analysed for this purpose. Besides, 
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classifier performance in real-world gene expression datasets often suffers from 
issues such as the class imbalance between disease and control samples and also 
missing gene expression values. However, the literature appears to suggest there 
is a lack of studies addressing these aspects for gene-expression classifier 
models. Therefore, class imbalance and missing value problems in microarray 
experiments are also investigated in this research.  
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3 MATERIALS AND METHODS 
3.1 Introduction 
In this chapter, the first type of datasets applied is discussed. Including a 
description of how it was produced and how it can be useful for this research. 
Then, ranking methods are discussed followed by a brief description of different 
imbalanced datasets and imputation methods used for handling missing values. 
The datasets applied are explained and the main method of Pareto Optimality 
method is examined in detail. 
3.2 Microarray Data Analysis 
Microarrays can be grouped as array data in biological datasets. The sequences 
comprise numeric values. Numerical expressions of micro sequences are 
express the activation level of genes. 
Microarray datasets have existed for two decades and they became challenging 
for machine-learning methods. It shows the generic characteristic of big data 
even with small sample sizes that present significant complexity (e.g., class 
overlaps, imbalanced classes, dataset shift). Establishing a predictive model 
with usually fewer than 100 samples and thousands of features makes the 
learning process more laborious. In the literature, several studies show us the 
most gene-expression values in a DNA microarray experiment are irrelevant in 
the classification of samples and only a fraction of them are necessary. When a 
classifier faces numerous number of irrelevant features, its accuracy 
performance inevitably decreases (Veronica Bolon-Canedo et al., 2015). 
Likewise, instance-based learners such as 𝐾-NN with Euclidean distance 
metrics are strongly affected by redundant features. A higher number of 
irrelevant features exponentially increases the demand for training instances to 
produce a predetermined level of accuracy (Haixiang et al., 2016). Furthermore, 
the models used have to deal with imbalanced classes, samples extracted under 
different conditions in both training and test datasets, dataset shift or the 
presence of outliers (Veronica Bolon-Canedo et al., 2015). 
3.2.1 Gene-Expression Data 
Genes are sequences of DNA. They create RNA then creates protein and are 
active in all biological functions in the living cells. Each gene has different roles 
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in the functions of biological vitality. If a gene is particular of interest from a 
research point of view, such decisions can be made by looking at the number of 
proteins that are produced by that gene. This is the definition of gene expression. 
The frequency of conversion of DNA→RNA→Protein of a gene is called the 
expression level of that gene. An increase in the level of expression is 
interpreted as the activation of a gene, and a decrease as the suppression of that 
gene. 
The expression level of genes can vary from cell to cell, as well as from case to 
case. For instance, a gene expressed in one tissue of our body may differ from 
another tissue or may not be expressed at all. On the other hand, the same cell 
can be found different expression level in particular situations. For example, a 
gene that is usually under-expressed may be more highly expressed during cell 
division. The level of gene expression may vary according to environmental 
factors outside the body. For example, a gene expressed at an ordinary level in 
a plant may be expressed of less or more during the adaptation of the plant to 
the environment. 
Microarray technology is used to determine the level of expression of genes. 
Changes in the expression levels of thousands of genes at the same time can be 
detected with the application of microarray techniques. The ability to compare 
several genes at the same time has enabled this technique to be widely used for 
different purposes. 
Microarray experiments can be arranged for various purposes. For example, the 
levels of expression of genes belonging to organisms in two different groups, 
such as patient and control groups are compared. The biomarkers of a disease 
can be identified by looking at whether or not the genes that are being compared 
are related to the disease according to their success in distinguishing between 
patients and healthy people. This technique can also be used to identify altered 
genes in cancerous as opposed to healthy cells. The presence of genes involved 
in cancer formation can be identified by investigating the factors that regulate 
their expression. In a different use of gene expression, levels are taken at 
different times in the same cell to find genes that vary in appearance according 
to the interaction of the organism to the environmental environment. 
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Regardless of the purpose for which the research is conducted, only a small 
portion of the thousands of genes evaluated maybe related to the situation under 
investigation. Therefore, selecting the genes associated with the research 
problem is of great importance in terms of solving that problem. Also, if the 
microarray data are analysed using machine learning methods, the presence of 
irrelevant data will both complicate the analysis and decrease the success of the 
technique. This study aims to develop multi-purpose approaches to improve the 
feature selection process for machine learning methods, where datasets have a 
high number of features. Microarray datasets mostly have small sample sizes 
because of limited diseased and healthy people data. The methods proposed in 
the study were tested on microarray data, which inherently possesses a large 
number of features. 
Microarray technology and the generation of gene expression data involve many 
processes. The process of the formation of data is not considered in this thesis. 
The data used in this study is existing microstructure data ready for analysis. 
Each row of data used is in a matrix format, which represents a sample of each 
gene. 
The methods proposed in this project to be used on gene expression datasets 
aims for the correctly classify samples with a smaller number of features. We 
mostly study with the two-class datasets (e.g., normal and disease) as compared 
to multi-class datasets. 
3.2.2 Imbalanced Data 
In real life, imbalanced data exists more frequently than balanced data (Lee and 
Zhu, 2011), as found in many research domains and also in bioinformatics 
(Japkowicz and Stephen, 2002). Most observed datasets have two general 
characteristics; the first is that they have two classes, and the other one is that 
class distribution is skewed. These problems are called binary and imbalanced 
classification problems, respectively. Commonly, the minority class is more 
interesting to research. However, common classification techniques biased 
towards the majority class on imbalanced datasets. As a consequence, the 
accuracy performance of the classifier can be very poor. Just because the 
classification methods are utilised to maximise the performance accuracy across 
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the entire dataset without considering contribution of minority and majority 
classes to training  (Kim, Chung and Lee, 2017). As minority class has a low 
impact on outcome, balancing its impact on the outcome should be addressed 
properly in order to get a better classifier performance. Balancing the dataset 
classes require analysing the characteristics related to samples and features 
concerning majority and minority of the cases. Moreover, the imbalance ratio 
(IR) should also be adequately examined. 
Resampling approach (Yang and Mao, 2010) is one of the main strategies 
suggested in the literature for analysing the imbalanced datasets. Additionally, 
a numerical arrangement in minority and majority class samples were 
performed to make the dataset balanced. Feature selection methods can also 
mitigate the circumstances related to class imbalance problem. The properly 
selection of subset of variables from a whole set of variables impacts the 
efficiency of the classifier performance. 
3.2.3 Imputation Methods for Data with Missing Values  
Numerous studies have been carried out on datasets with missing values 
concerning to apply imputations on them. In recent years, research studies have 
crafted improvements on imputation methods.  
As in many other types of experimental data, microarray experiments to create 
gene expression data often include missing values (MVs) (Troyanskaya et al., 
2001; Oba et al., 2003; Celton et al., 2012; Chai et al., 2014). Among the 
reasons why experiments produce such MVs include faults that happen during 
fabrication or experiments, or microarray image related problems (e.g., image 
corruption, insufficient resolution). 
A basic strategy for approaching the problem of missing values is that simply 
eliminating samples having them. However, this strategy does not work for 
microarray data (Souto, Jaskowiak and Costa, 2015). When the samples 
containing MVs are eliminated from the gene expression dataset, the results of 
the classification can be biased to one of the classes. This approach can only 
work for gene expression profiles that contain very few MVs (< 5%). 
Nonetheless, when a high percentage (>95%) (Haixiang et al., 2017) of the 
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values of one feature are missing then that variable can considered to be 
removed.  
Generally, statistical metrics were effectively used in algorithms to impute 
missing values. A widely used statistics approach in this matter is simply 
imputing the missing values with zeros or feature mean (Alizadeh et al., 2000). 
One problem with the statistics approaches is that they do not consider 
correlation between variables (Troyanskaya et al., 2001). However, 
interestingly, imputation with statistical methods such as getting feature mean 
or feature median simply reported to be almost equally well in the classifier 
performance as compared to complicated imputation methods presented in the 
literature (Souto, Jaskowiak and Costa, 2015). 
3.3 Experimental Datasets 
3.3.1 Colon Cancer 
Colon cancer is a disease when diagnosed in early-stage survival rate is very 
high. The colon cancer dataset consists of 62 samples and 6500 genes for each 
sample (Alon, 1999). The dataset consists of colon tissue samples marked as 
positive (disease) and negative (healthy) groups. One class is the positively 
marked group, 40 tumour tissues, and the remaining class is the negatively 
marked group, 22 normal tissues. 
3.3.2 DLBCL (Lymphoma) 
This dataset consists of 5469 sets of gene expression values for 77 patients 
(Shipp et al., 2002). These patients are distinguished from each other based on 
their pre-treatment biopsies. One malignancy group include 58 samples for B-
cell lymphoma (DLBCLs), and the remaining malignancy group include 19 
samples (control group) for follicular lymphoma (FLs). 
3.3.3 DUKE Breast Cancer 
This dataset contains 7129 genes for 44 samples. They are classified according 
to oestrogen receptor ER+ (23) and ER-(21) (West et al., 2001). 
3.3.4 CNS (Central Nervous System) Embryonal Tumour 
Central Nervous System (CNS) Embryonal Tumour is a disease with a high 
mortality rate. CNS Embryonal Tumour dataset that we study consists of sixty 
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patients, and 7129 genes for each sample (Pomeroy et al., 2002).  The dataset 
separated into two main groups, alive and not alive. One class is the survivors, 
twenty-one patients, whom were alive at the end of the treatment. The remaining 
class, thirty-nine patients, are those that were died during the treatment. 
3.3.5 Ovarian Cancer 
Ovarian cancer is a woman disease where early diagnosis increases the survival 
rate. The ovarian cancer dataset consists of 253 samples, 6000 genes per sample 
(Petricoin et al., 2002).  The dataset separated into two main groups, cancer and 
not cancer. One class is the normal group, 91 participants, whom were the 
control samples. The remaining class, 162 participants, are those that were 
diagnosed with the ovarian cancer disease. 
3.3.6 DLBCL (Blood) Cancer 
Diffuse Large C B-cell Lymphoma (DLBCL) is a blood cancer disease caused 
from abnormal B-cell growth with a modest survival rate. The DLBCL dataset 
consists of 47 samples and 4026 genes (Alizadeh et al., 2000) The dataset 
separated into two different DLBCL types, "germinal centre B-like" and 
"activated B-like". One class presents the gene expression characteristics of the 
germinal centre B-like DLBCL group, 24 patients, and the remaining class 
presents the gene expression characteristics of activated B-like DLBCL group, 
23 patients. 
3.3.7 Brain Cancer Data 
The brain cancer dataset consists of 50 samples, 6706 genes per sample (Bredel 
et al., 2005). The dataset classified into three glioma subtypes. First glioma 
subtype is the pure glioblastomas, thirty-one samples. Second glioma subtype 
is the oligodendroglial morphology, fourteen samples. The remaining glioma 
subtype is the grade 1-3 astrocytomas, five samples. 
3.3.8 Lung Cancer Data 
Lung cancer is a disease with a very low survival rate. The lung cancer dataset 
consists of sixty-six samples, filtered 3312 (12600 original genes number) genes 
per sample (Garber et al., 2001). The dataset morphologically classified into 
four groups. First group is the squamous cell carcinomas, seventeen samples. 
Second group is the large cell lung cancers, five samples. Third group is the 
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small cell lung cancers, four samples. The remaining group is the 
adenocarcinoma, forty samples. 
3.3.9 Prostate Cancer Data 
 Prostate cancer is a disease with high survival rates. The prostate cancer dataset 
consists of 112 samples and ~26,000 genes (Lapointe et al., 2004). The dataset 
has three classes. First class contains the control group, forty-one healthy 
samples. Second class is the disease group, sixty-two prostate cancer samples. 
The remaining class is another disease group, nine lymph node metastases 
samples. 
3.3.10 Endometrium 
Endometrial cancer is a women disease with high survival rates. The 
endometrium cancer dataset consists of forty-two samples and X genes per 
sample (Risinger et al., 2003). The dataset classified into four groups. First 
group is serous papillary, thirteen samples. Second group is the clear cell, three 
samples. Third group is endometrioid cancers, nineteen samples. The remaining 
group is the seven age-matched normal endometria. 
3.4 Data Validation 
The datasets are first separated into training and test parts in order to avoid 
mixing samples. This separation is justified in the literature (Bolón-canedo et 
al., 2014). Data split ratios selected from the literature are the widely used 80% 
training and 20% test (Ding and Wilkins, 2006), and to compare learning levels 
60% training and 40% test (Luo et al., 2011).  This process is repeated 25 times, 
so that 25 dataset variations are gained. Then, 𝐾-fold cross-validation is utilised 
for training which could be 5-fold, 10-fold and Leave-one-out (LOO).  This high 
amount of variety and three cross-validations creates multiple altered conditions 
employed in the proposed multi-criteria decision framework to scrutinise 
stability given such conditions. 
3.5 𝑲-Fold Cross-Validation 
𝐾-fold Cross validation is a method that splits the dataset into 𝑘 different 
subdivisions where one subdivision used as the testing set whereas the 
remaining 𝐾 − 1  subdivisions used for training the computational model. 
Blagus (2015) emphasised that it is essential to apply the correct cross-
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validation (CV) in feature selection and classification. If the data is not split into 
training and test proportions to validate feature selection, CV can often be used 
as a measure of performance (Webb et al., 2010)., training should be adequately 
separated from the test on the feature selection process.  CV should be used on 
the training data. Then, the test data should only be used for classification 
purposes.  
This research study used the cross validation as to resample the datasets to 
evaluate the classifier as well as the feature selection performance. The 5-fold, 
10-fold and leave-one-out cross-validation methods are applied to test how 
filtering methods and a wrapper method perform in different training folding 
circumstances.  
3.6 Classification 
The 𝑘-nearest neighbour (𝑘-NN) is one of the most widely used non-parametric 
classifiers (Chuang et al., 2011). It is not only conceptually straightforward and 
easy to implement but also computationally efficient. Noise in data volumes 
does not seriously affect its performance (Cover and Hart, 1967). It was deemed 
a suitable classifier for use in this study. 
3.6.1 The 𝒌-nearest neighbour (𝒌-NN)  
𝑘-NN is a distance-based classifier in which Euclidean distance is commonly 
used as the distance metric, and there is a potential risk of tied results when even 
numbers are used. If this happens, tied results are solved using a random 
procedure. Thus, the use of even number was avoided. Odd numbers of 
neighbourhoods were applied to avoid any tied results from the classifier and 
the 𝐾 values are selected ranged from 1 to 11. Applied distance metric is 
Euclidian metrics. 
3.6.2 Support Vector Machine (SVM) 
Support Vector Machines is a learning machines-based classifier, emerged from 
statistical learning theory (Vapnik, 1999). SVM, basically separates samples 
into two groups aiming to maximize the margin between them (Figure 3-1). 
Margin based classification for finding the optimal separation hyperplane 
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subject to:  (𝑤𝑡𝑥𝑖 + 𝑏)𝑦𝑖 ≥ 1 − 𝜉𝑖 , 𝜉𝑖 ≥ 0, 𝑖 = 1, … , 𝑛 (2) 
where: x is the set of features,  
 n is the length of samples,  
 y is the class,  
 w is the weights of the hyperplane,  
 b is the bias of the hyperplane,  
 C is for the regularization,  
 𝜉𝑖 is the slack variable which is a value indicating   
deviation of samples from the hyperplane.  
 
 
Figure 3-1 Illustrative example of SVM classification (Liang et al., 2016).  
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3.7 Ranking Methods 
𝑡-test, Entropy, Bhattacharya, ROC, Wilcoxon tests will be used as the ranking 
methods for producing feature subsets. The definitions of these methods are 
summarised below. 
3.7.1 Two sample 𝑻-test 
The 𝑡-test is clearly the most popular test, and it is a parametric test. It is applied 
to determine if the average difference between data for two independent 
variables is significant(Fox and Dimmic, 2006). 
The 𝑡-test is expressed by; 








    Equation 3-1 
Using a 𝑡-statistic can be challenging because genes having a very low variance 
can skew variance estimates (Tusher, Tibshirani and Chu, 2001). Another 
disadvantage is its applications on a small number of samples such as the 
microarray datasets. In such datasets it is reported that t-test may fail to select 
optimal set of genes (Murie et al., 2009). Therefore, the power of a 𝑡-test has 
been questioned along with the importance of variance modelling (Mary-Huard, 
Picard and Robin, 2006). A variable in the dataset might have identical means 
but may differ in variance among classes. In such a case, t-test can miss that 
variable even though the variance might be significant for the analysis of the 
dataset (Baldi and Brunak, 2001).  These issues have led to the proposal of 
various alternatives with the aim of better accuracy in variance estimation.  
3.7.2 Entropy 
In its non-parametric form, relative entropy, also known as Kullback-Liebler 


















2) (𝜇1 − 𝜇2)
2]  Equation 3-2 
After the statistical calculation is completed for every gene, genes with the 




This is similar to Kullback-Leibler distance but considers a different distance 
metric between two distributions.  
The Bhattacharyya coefficient (Guorong, Peiqi and Minhui, 1996) is calculated 
as: 
𝑟𝑘 = −𝑙𝑛 (∫ √𝑁(𝑊𝑘
+)𝑁(𝑊𝑘
−)𝑑𝑥)   Equation 3-3 



























The output ranking list becomes the input for Pareto optimality. 
3.7.4 Receiver Operating Characteristic (ROC) Analysis 
The receiver operating characteristic (ROC) curve helps to interpret binary 
classification tasks with the proportion of true positives to false positives, while 
the difference in the threshold value varies (Metz, 1978; Fawcett, 2006). The 
true positive (sensitivity) and the false positive (1-specificity) rates are located 
on the ROC curve as points for different threshold values on the vertical axis 
and the horizontal axis, respectively (Bradley, 1997).  
Table 3.1 Confusion Matrix 
  Predicted 
  Negative Positive 
Actual 
Negative True Negative False Positive 
Positive False Negative True Positive 
 
At the end of a binary classification task, four possible outcomes are occurred 
using a confusion matrix: true positive (TP), false positive (FP), true negative 
(TN), false negative (FN). Their formulas are as follows. 
TP = Correctly classified positive samples 
TN = Correctly classified negative samples 
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FP = Incorrectly classified positive samples 
FN = Incorrectly classified negative samples 
The outcomes are required information to calculate true positive rate (TPR) and 




    Equation 3-4 
and 
𝐹𝑃𝑅 =  
𝐹𝑃
𝐹𝑃+𝑇𝑁
    Equation 3-5 
Then TPR and FPR are used to plot the ROC curve and calculate the AUC. The 
ROC curve can be used to rank feature subsets for the Pareto optimal models. 
The models are tested based on the area under the curve (AUC) aiming to find 
the gene subsets having the highest AUCs. The figure illustrates how the ROC 
























Mann-Whitney U-Test (or Wilcoxon Rank-Sum Test) differs from the statistical 
tests being non-parametrically testing equality of two similarly distributed 
populations. Without fulfilling the parametric test assumptions, the duration of 
the significance test of the difference between the two means can lead to 
reaching the conclusion (Nguyen et al., 2015). The Wilcoxon rank-sum test is 
used as alternative statistical filter test. This test differs from the above-mention 
methods being a non-parametric and hence no assumption is made about the 
distribution of the date. 
Using two formulas, two U-statistics candidates are calculated. From these, 𝑈1 
The number of observations and total sequence number for Sampling 1; If 𝑈2 
uses the number of observations and the total number of sequence numbers for 
Sampling 2. The formulas are: 
𝑈1 = 𝑅1 −
𝑛1(𝑛1+1)
2
  Equation 3-6 
𝑈2 = 𝑅2 −
𝑛2(𝑛2+1)
2
  Equation 3-7 
Where 𝑛1 is the sample size for Sampling 1; 𝑅1 Sum of sequence numbers for 
Sampling 1; 𝑛2 Sample size for sampling 2; 𝑅2 is the sum of the sequence 
numbers for Sampling 2. For the control, the sum is taken for 𝑈1and 𝑈2. This 
value should be equal to the product of the two sample volume numbers; so 
𝑈1 + 𝑈2 = 𝑛1. 𝑛2  Equation 3-8 
The U-statistic, which is less than the 𝑈1 and 𝑈2 values found, is used in the 
significance table. If the sample volumes are large, the following standard 
normal distribution approach is used to find the level of significance: 
𝑧 = (𝑈 − 𝑚𝑈)/𝜎𝑈  Equation 3-9 
Where 𝑧 is the 𝑧-score used in standard normal distribution tables; If 𝑚𝑈 and 
𝜎𝑈  𝑈 if the null hypothesis is true, then the mean and standard deviation for U 
is They are found by the following formulas: 




  Equation 3-11 
57 
 
3.8 Pareto Optimality (PO) Method 
Multi-objective optimisation can involve the maximisation or minimisation of 
a vector function 𝑔. The target vector function contains a group of 𝑚 parameters 
(decision variable) and a group of 𝑛 objectives. PO transforms a scalar objective 
into a vector and can be expressed as follows: 
minimise or maximise the function: 




      Equation 3-13 
where 𝑚 and 𝑛 are the numbers of genes(parameters) and responses(objectives) 
respectively, and 𝑡 = (𝑡1, … , 𝑡𝑚) and 𝑧 = 𝑔(𝑡) are determined as the decision 
and objective vectors, where 𝑇 and 𝑍 represent the parameter and the objective 
spaces (Zitzler and Thiele, 1999). The solution set includes all decision vectors, 
which have a minimum of one optimum objective value. The collective set of 
non-dominated solutions are known as PO solutions. A non-dominated solution 
is where the values of target vector functions came to their limits and no more 
optimization could be possible based on the given parameters.  
If the target vector function is to maximise the objective under (3), 𝛽 dominates 
𝛾, or in other words 𝛾 is dominated by 𝛽: 
∀𝑖  ∈ {1, 2, . . . , 𝑥} 𝑔𝑖(𝛽) ≥ 𝑔𝑖(𝛾)  ∧  ∃𝑘∈ {1, 2, … , 𝑥}  𝑔𝑘(𝛽) > 𝑔𝑘(𝛾).    
Equation 3-14 
Figure 3-3 shows an illustration of PO solutions where there are two cases. If a 
solution has maximum values for all objectives, it is the optimum and ideal 
solution. As seen in Figure 3-3.(a), the optimal solution covers all other 
solutions for all objectives. However, if a solution has a maximum value for at 
least one objective and up to the most n-1 objectives, it is one alternative 
solution. Likewise, a multi-criteria selection case with two objectives that are 
maximised and five solutions is represented in Figure 3-3(b). Four solutions (A, 
B, C, and E) are not dominated by any other solution, so the non-dominated 
solutions are Pareto-optimal solutions. However, solution D is dominated by 
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solution E in both objectives, and so it is not a Pareto-optimal solution. It can 
be expressed in two ways, E dominates D, or D is dominated by E. If solution 
E does not exist, then solution D is a Pareto-optimal solution.   
 
Figure 3-3. Demonstration of a maximisation case with two objectives. 
If multiple methods are performed and all of them are combined, this creates a 
hypersphere of features for PO. If one method is performed and combined with 
different samples of a same dataset, it creates a hyperplane of features for PO. 
Multiple methods are creating as possible as major class divided into the equal 
size with minor class, trade-off/ boundary sensitivity will become healthier. 
 
Four objectives example for PO 
To simplify the PO, there is an example with 4 objectives and 6 samples.  For 
the PO example specifically, features in a dataset are arranged in an optimal 
form, without affected from further parameter changes. 
There two aims we want to from an optimal outcome: 
1. One outcome maximises total surplus 
2. One outcome is preferred by a feature over all other sets of feasible 
subsets 
Pareto optimal response is achieved when there is no room providing a better 
feature set that is adding or removing a feature will produce negative outcomes 
























































Table 3.2 Simplified 4 Objectives and 6 Samples Dataset Example for PO 
Features 𝑃1 𝑃2 𝑃3 𝑃4  Total 
Surplus 
  
Feature A 30 55 30 50 → 165 →  Not 𝑃𝑂 
Feature B 25 30 65 60 → 180 → 𝑃𝑂 
Feature C 30 55 55 90 → 230 → 𝑃𝑂 
Feature D 15 20 75 90 → 200 → 𝑃𝑂 
Feature E 10 15 65 55 → 145 →  Not 𝑃𝑂 
Feature F 10 35 35 95 → 185 → 𝑃𝑂 
 
𝑃𝑛 named our samples as Person (Sample) and each row represents of 
comparison vector. As seen on Table 3.2 presents for each sample between 
𝑃1to𝑃4 for each of available features A, B, C, D, E and F.  
Basically, if these 4 individuals’ feature expression values compare, they can be 
identified as healthy or disease sample according to expression values. Our 
objective is here according to higher activation number find out Pareto Optimal 
solution. 
Pareto optimal feature subset is achieved after a variety of candidate feature 
subsets are tested and when no further improvement can be possible. 
Explanations written in two ways because of multi dimension makes harder to 
understand PO process, first according to mathematical calculations and 
secondly distinguishing value and meaning according to PO. 
Mathematically; 
First, Feature A→B (A to B), A→C, A→D, A→E, A→F expression values 
compares one by one. Feature B could not dominated A but Feature C dominates 
feature A in all dimensions so A is dominated and eliminated. Also, D,E,F stays 
and continue to compare feature vectors. 
Continue with B,C,D,E,F. 
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Second, Feature B→C, B→D, B→E, B→F expression values compares one by 
one. B dominates feature E in all values so it is eliminated. Rest of the features 
could not dominated B so B stays in PO subset. 
Continue with B,C,D,F 
Third, C→D, C→F expression values compares one by one. They could not 
dominate each other. Thus, there is no elimination.  
Lastly, D→F compared. They could not dominate each other. Thus, there is no 
elimination. 
Final PO subset is feature B, C, D, F. 
 
In other words, PO feature selection steps explained with numeric and logical 
information as below. 
• Feature B is in PO subset; B→C (B to C), For the  𝑃3 sample goes from 
65→55 (B dominated C for Sample 𝑃3). 
• C is in PO subset 30 and 55 are max features for sample 𝑃1 and 𝑃2 
respectively (C is dominated (distinguishing) feature to identify 𝑃1 and 
𝑃2). 
• D is in PO subset from D→C, Sample  𝑃3 goes from 75→55 (D is 
dominated C for sample 𝑃3 it is useful to distinguish the sample). 
• From feature A→C expression values for all samples equivalent or 
higher so A is not in the PO subset 
• From feature E→D, all expression values higher so E is not a PO 
solution. D dominated E in all expression values. Thus, E is not useful 
to distinguish any sample. 
•  Until this step feature B, C, D become dominant genes. Until this step, 
there is no distinguishing feature for 𝑃4 yet. 
• From feature F→B or F→C or F→D, Feature F dominates rest of the 
subset 95 but not for other samples. Thus, F added to PO subset, but no 
other features removed from final subset. 
• Final PO subset is feature B, C, D, F. 
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3.9 Performance Evaluation 
To evaluate the classification performance of the proposed framework, the 
following formula will be used. 
Accuracy =
TP + TN










where TP is the correctly classified positive samples, TN is the correctly 
classified negative samples, FP is the incorrectly classified positive samples, 
and FN is the incorrectly classified negative samples.  
3.10 Conclusion 
This chapter presented an overview of the Pareto Optimal methodology that is 
utilised throughout this research. In this chapter also described the datasets, the 
ranking methods, and statistical validation and performance evaluation 
techniques that are employed in this research to evaluate the proposed 
framework performance. The effectiveness of the proposed framework tested 
on ten datasets and three data types. The next chapter investigates areas for 




4 A PARETO OPTIMAL MULTI-OBJECTIVE 
FRAMEWORK FOR AGGREGATED 
DISCOVERY OF DISEASE-RELATED GENES  
4.1 Introduction 
One of the most significant challenges in bioinformatics is to identify the 
correlation between genes and diseases. Microarray data is particularly valuable 
as it contains a large amount of information about of genes. However, in 
general, only a small number of genes have a significant relation with certain 
diseases. During the last decade, a large amount of research has been performed 
in this area (Nguyen et al., 2015). The objective of microarray data classification 
is to create an efficient and practical framework that can differentiate between 
gene expression in samples so that they can be determined as healthy or 
diseased. (Chuang et al., 2011).  
4.2 The Problem of Gene Selection 
Various gene selection studies try to explain the occurrence of cancer in terms 
of a few genes present in microarray datasets, and their common objective is 
simply to maximize  accuracy (Saeys et al., 2007). However, efficiency should 
not be the only objective; the complexity of the method should also be taken 
into account. Furthermore, objectives should also include robustness against 
data variation in different datasets of new samples (Bolón-Canedo, Sánchez-
Maroño and Alonso-Betanzos, 2016) as well as achieving the most 
comprehensive biologically meaningful subsets (Sarac et al., 2015). 
Feature selection methods are the most common techniques used to identify 
essential genes from a large set of genes (Bolón-canedo et al., 2014). Filter and 
wrapper methods are the application models generally used for gene selection 
(Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 2016). Such feature 
selection methods have both strengths and weaknesses (Saeys et al., 2007), and  
no  technique is considered universally useful in all situations (Ang et al., 2016; 
Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 2016). 
Filter methods are considered to be one of the best options to reduce feature 
dimensionality and thereby alleviate the need for the computational resources 
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required (Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 2012). 
However, they have lower accuracy as compared to wrapper methods because 
they provide only general subsets (Saeys et al., 2007; Wang et al., 2013; Bolón-
canedo et al., 2014). Moreover, utilising these techniques can lead to the 
significant problem of over-fitting, as the genes identified during training may 
not necessarily fit well with the test data (Yang et al., 2015). 
Additionally, one of the most challenging topics when applying these methods 
is their robustness. Most recent filter techniques focus on information theory. 
An alternative approach is to use wrapper techniques, but due to their high 
computational cost and the risk of over-fitting, these are generally avoided 
(Bolón-canedo et al., 2014). Nonetheless, wrapper techniques provide the best 
possible subset for a particular type of model and allow the relationships 
between features to be evaluated. However, they are considered to introduce 
bias based on the selection of subsets and are computationally intensive with a 
high risk of overfitting (Jovic, Brkic and Bogunovic, 2015). Therefore, recent 
reviews have mentioned that there is a potential to improve accuracy and 
robustness through the use of ensemble technique which combine different 
methods (Saeys et al., 2007; Bolón-Canedo, Sánchez-Maroño and Alonso-
Betanzos, 2012, 2014). 
4.3 Ensemble Feature Selection Methods 
Ensemble feature selection methods use either different samples reflecting 
variations of the dataset, or various methods with the same dataset (functional 
diversity), or have a mixture of both (Bolón-Canedo, Sánchez-Maroño and 
Alonso-Betanzos, 2016). Data diversity may cause a shift in the dataset (Bolón-
canedo et al., 2014), which appears when the input and output pairs differ 
between training and test datasets. That means during the split of the data into 
training and test datasets, critical samples are that grouped in one-fold could 
characterize one class among the remaining classes. Thus, results from 
individual folds of the training set may not represent the data accurately enough 
for successful feature selection. Functional diversity provides many sets of 
results, and hence the aggregation of such multiple results does not preserve 
valuable information. As a result, there is a need to utilize both data diversity 
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and functional diversity so that more comprehensive and representative subsets 
can be identified.  
Ensemble methods are widely proposed for classification (Bolón-Canedo, 
Sánchez-Maroño and Alonso-Betanzos, 2014), and they tend to provide more 
robust results than  single versions of any one method (Seijo-Pardo et al., 2015). 
An advantage of the ensemble approach as compared to the feature selection is 
to eliminate the need for computational models to seek for a feature selection 
method fitting to their datasets. (Bolón-Canedo, Sánchez-Maroño and Alonso-
Betanzos, 2012). As a result, ensemble approaches have become widespread 
and are now commonly found in bioinformatics applications. 
Various aggregation techniques are described in the literature, such as majority 
voting, stacking and cascading, bagging and boosting (Alpaydin, 2010) to name 
only a few. The aggregation technique in an ensemble method is an essential 
part of the disease-related gene selection process. However, the literature 
appears to suggest that there is a lack of robust multi-criteria aggregation 
methods for gene selection (Bolón-Canedo and Alonso-Betanzos, 2019). 
Existing ensemble methods have a limited ability to make decisions during the 
selection of genes because they mostly rely on voting when aggregating the 
results of the method used. Voting aggregation may eliminate essential disease-
related genes and is limited in the ability to identify biologically valuable genes 
(Montague and Aslam, 2004; Wu et al., 2009). 
A small variation in the training data set can significantly alter gene selection 
and thus can significantly affect the stability of the system (Nguyen et al., 2015). 
For example, genes identified using feature selection from 10-fold cross-
validation of training data can significantly differ from those when using the 5-
fold cross-validation of the same training data. Luo et al. (2011) mentioned that 
previous studies revealed that the feature selection approaches chosen are more 
crucial than the classification methods used. This study focused on optimising 
the results of multiple methods applied to different size of training sets. 
Partitions are prepared similar to the study of Lue et al. We proposed the 
partitions as 40% / 60% and, 20% / 80% for test and training sets, respectively. 
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In this chapter, firstly a novel framework called Model-1 is proposed using PO 
for gene selection in order to solve the overfitting of the classifier and stability 
problems in feature selection. Then the proposed framework is used in two 
different set of partitions as mentioned above providing better results in each 
step. PO, which was originally used in engineering and economics, provides 
one of the best trade-off according to the objective function involved (Shoval et 
al., 2012). The aim of this study is, therefore, to investigate PO as part of an 
ensemble feature selection framework combined with filter techniques and 𝐾-
fold cross-validation for the selection of genes from gene-expression microarray 
datasets. Then, the feature subsets extracted are combined as a consensus gene 
subset. The results of the proposed PO-based framework are shown to yield 
better stability than that of common single filter methods. Secondly, this work 
focuses on the development of a multi-objective aggregation framework for 
gene selection. The framework involves aggregating the different results 
obtained from a wrapper method in a novel way using Pareto optimisation. PO 
is utilised for aggregating and evaluating the result of the wrapper method. It 
selects disease-related genes according to their scores without any user 
intervention. PO collects information of all genes throughout different data 
variations and eliminates genes having insufficient discrimination ability while 
retaining genes efficient discrimination ability. Wrapper methods may provide 
different results for each variation of training data and may over-fit to it’s test 
data. Meanwhile PO collects individual results and combines them in a common 
subset with only non-dominant genes. Genes in the common subset cover all 
training variations and are more robust to alterations. In this way, the overfitting 
problem is mitigated. 
The aim of the present study is to construct a novel cross-validated framework 
that provides stable and robust generalised aggregated decision-making ability 
owing to the use of PO. PO combines random inputs and creates a single output. 
Furthermore, the results of PO are applicable to the aforementioned random 
feature subsets (Li, Wu and Hu, 2008). By using PO, an efficient and feature 
selection process selects genes straightforwardly. It will also be utilised to apply 
the classification process to just an ensemble subset of training datasets of 
microarray gene expression data (Yang and Mao, 2011). The goal is to provide 
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a consensus result, which will be independent of any classifier (such as K-
nearest Neighbours, or a Support Vector Machine). 
4.4 PO-based Multi-Criteria Framework  
The proposed framework is designed to include several different feature 
selection methods combined with Pareto optimality. Two distinct frameworks 
where PO is used to combine the results of the selected features are developed 
and compared with traditional feature selection methods, the details of which 
are discussed below. 
Filter and wrapper methods are common feature selection techniques. Filter 
techniques rank features based on their relationship with a univariate scoring 
metric with a class label (Hong and Cho, 2009). In this study, several well-
known methods are combined with PO; namely, the t-test, Entropy, 
Bhattacharya, ROC, and Wilcoxon test. For the sake of comparison, they are 
used one by one in the proposed framework to create rankings of genes related 
to each dataset. The standalone results of these filter methods without PO are 
also recorded to compare with those from the proposed framework. 
The classes in each dataset are divided into five subsets of samples. This process 
is repeated 5 times. Thus, the different variants of the test and training parts 
contain independent samples. Each variant is repeated ten times to discover the 
performance of the tests in a more sensitive way. 
The first study used a ratio of 20% test and 80% training set sizes.  As in the 
study by (Luo et al., 2011), the second study used 40% test and 60% training 
sets. These two experiments were carried out to observe the effect of different 
partition sizes for models with and without PO. 
The preparation of datasets for the wrapper method included the following 
steps. 25 different data splits were created from the original datasets, and each 
training-test split contained independent samples. 80% training and 20% test 
sizes were utilised for the first study. Moreover, to compare the effect of 
training–test ratio, a 60% training and 40% test ratio was used as in previous 
research (Luo et al., 2011). Resampling performed with cross-validation is 
repeated ten times and then performance of the proposed framework was 
evaluated. When high-dimensionality becomes an issue in the use of ensemble 
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methods, filter methods are selected as a preliminary solution to decrease the 
number of features (Bolón-Canedo, Sánchez-Maroño and Alonso-Betanzos, 
2012, 2014; Ogutcen et al., 2016). Features were ranked using ensemble filter 
methods to gain a relatively small but comprehensive feature pool for SFS 
(Ogutcen et al., 2016). Their rankings were used by PO to create the common 
feature pool. Filter methods are useful due to their rapid computation and 
scalability, but unlike wrapper methods they do not take into account feature 
dependencies (Saeys et al., 2007). 
4.5 Integration of the Wrapper Method with the Proposed 
Framework 
Second stage with the proposed framework introduces a novel aggregation 
approach for wrapper-based ensemble methods. Sequential forward selection 
SFS is utilised for feature selection, and Pareto optimality is used to aggregate 
the selected features. The critical element of aggregation by PO is to consider 
all of the data together and to collect all of the results into one common solution 
set. Moreover, in this framework, PO is not dependent on the feature selection 
method used. Any other feature selection method or indeed different feature 
selection methods can be used in this framework. 
SFS is a common and straightforward wrapper technique, and so it is employed 
here to demonstrate how PO improves the efficiency of feature selection 
methods. Unlike voting methods, PO does not rely on a majority decision. It 
considers all expert decisions as a vector and evaluates all possible solutions in 
multi-dimensional space. In this decision space, if a solution is not dominated 
by other features throughout all training set variations, that gene is selected in 
the common subset. This common subset is called the PO solution.  
For comparison, many results come from either different local data variations 
or different decisions from experts utilised (individual methods) with the same 
data. In other methods, when an expert has been added to an ensemble model, 
each feature is selected according to the voting method. If a possible disease-
related gene is ignored by the majority of experts, this useful gene cannot be 
chosen. Hence, it cannot contribute to the classification results. However, one 
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expert or a minority of experts may have discovered that gene, but the ensemble 
structure may not use all expert decisions. 
On the other hand, when a feature is selected by one of the experts in at least 
one training variation, and if it is statistically crucial at any level and not 
dominated by other selected features, PO considers that feature in the common 
subset. PO does not eliminate possible features as in voting methods. Thus, the 
PO-based multi-criteria framework keeps all non-dominant genes containing all 
statistically meaningful information. This makes PO a better and more effective 
aggregation method, which can produce a more comprehensive subset. To show 
the advantages of PO in the proposed framework, SFS is employed individually, 
and the SFS results are presented for comparison. For classification, the K-
nearest neighbours (kNN) is used which is one of the most commonly used and 
straightforward classifiers (Chuang et al., 2011). 
4.5.1 Cross-Validated Aggregated Gene Selection using Filter Methods 
The proposed framework uses several different feature selection methods 
together as well as PO in Model-1 as illustrated in Figure 4-1. Model-2 as 
illustrated in Figure 4-2 is an unassembled version of Model-1, which is created 
to show how the ensemble filter methods perform using a single feature 
selection method. Meanwhile Model-3 as illustrated in Figure 4-3 focuses only 
on the performance of the filter tests. The same assessment as in Model-1 is 
conducted for this model without Pareto Optimality. There is no evidence that 
it was compared with traditional single feature selection methods or, most 
importantly, that cross-validation was carried out to assess the generalisation 
ability of the model independently. After the resampling of the data is 
completed, %20 of the data were randomly selected, and average classification 
accuracy values for both training and test datasets were evaluated. Details of all 
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Figure 4-1. Flowchart of the proposed framework using Pareto Optimality on 
paired-up features of Filter Methods (Model-1) 
Model 1: 
a) The dataset is divided into training and test cases and different dataset 
(20% test and 80% training or 40% test and 60% training). 
b) 𝐾-fold (5, 10 and LOO) cross-validation is applied to the training data 
sets (80% and 60%). 
c) The filter methods t-test, entropy, Bhattacharya, ROC, and Wilcoxon are 
used to rank the features. Each filter method is applied to each fold and 
ranked features are obtained. For the applied filter method, the ranked 
features of n-folds paired up. 
d) The paired-up features from each filter test are further combined using 
PO (Figure 4-1). This will result in one subset of features. 
e) The final gene set is formed at the end of PO process. The duplicated 
genes that reside in the final gene set will then be removed. This will 
yield unique subset of a consensus gene subset.  
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f) The genes that derived from the training data (consensus gene subset) 
using the PO analysis is validated using the test data. The test datasets 
(20% and 40%) are formed in two separate cases and organised using 
the consensus gene subset to validate our framework (aggregated gene 
selection using filter methods).  
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Figure 4-2 Flowchart of the proposed framework using Pareto Optimality on 
paired-up features of the applied Filter Method (Model-2) 
Model 2: 
a) The dataset is divided into training and test cases and different dataset 
(20% test and 80% training or 40% test and 60% training). 
b) 𝐾-fold (5, 10 and LOO) cross-validation is applied to the training data 
sets (80% and 60%). 
c) Different than the Model-1, the filter methods t-test, entropy, 
Bhattacharya, ROC, and Wilcoxon are solely used to rank the features. 
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Each filter method is applied to each fold and ranked features are 
obtained. For the applied filter method, the ranked features of n-folds 
paired up. The paired-up features of the applied filter test are combined 
using PO (Figure 4-2). This will result in one subset of features. 
d) The final gene set is formed at the end of PO process.  
e) The genes that derived from the training data using the PO analysis is 
validated using the test data. The test datasets (20% and 40%) are formed 
in two separate cases and organised using the consensus gene subset to 
validate our framework (aggregated gene selection using filter 
methods).  
f) The kNN is applied as the classification technique to evaluate our 
framework. 
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Figure 4-3 Flowchart of the proposed framework without Pareto Optimality 






a) The dataset is divided into training and test cases and different dataset 
(20% test and 80% training or 40% test and 60% training). 
b) 𝐾-fold (5, 10 and LOO) cross-validation is applied to the training data 
sets (80% and 60%). 
c) The filter methods T-test, Entropy, Bhattacharya, ROC, Wilcoxon (Fox 
and Dimmic, 2006; Nguyen et al., 2015) tests are respectively used 
alone without PO (Figure 4-3), and subset sizes that yield the highest 
accuracy from Model-1 are chosen as in the same K-level.  
d) For the applied filter method, the ranked features of n-folds paired up.  
e) The kNN is applied as the classification technique to evaluate our 
framework. 
4.5.2 Cross-Validated Aggregated Gene Selection using Filter-Wrapper 
Combination 
This section describes the proposed novel multi-objective framework for gene 
selection. The SFS method was utilised to identify the most strongly disease-
related genes, as seen on Figure 4-4. Due to the heavy computational burden of 
wrapper methods, before applying the wrapper technique, the number of 
features are decreased through the use of multiple filtering methods; namely, 
the Bhattacharya, Entropy, ROC, t-test, and Wilcoxon tests. This makes feature 
selection using the wrapper methods faster and more effective. The multi-
criteria framework is illustrated in Figure 4-4, and its steps are as follows. 
a) The dataset is split into test and training sets (20% test and 80% training 
or 40% test and 60% training) and numbers of feature dimensions are 
decreased in the selected feature pool. 
b) Cross-Validation: 𝐾 -fold (LOO, 10, 5) CV is applied to the training part 
of the datasets. 𝐾-fold preparation: Conducted to apply the SFS to the 




c) SFS selects genes from each fold, and each fold forms a vector of fixed 
size features for PO. After many experimental trials, we set the size of 
feature vectors to 10. 
d) Common subset: Duplicated genes are removed from the resulting gene 
set, and a common subset is established using this unique gene content. 
e) The PO solution set is ready for classification. 
f) For the classification task, the kNN classifier (1, 3, 5, 7, 9 NN) 
respectively is applied to test sets (20% or 40%). 























Figure 4-4 Flowchart of the proposed framework using Pareto Optimality on 
paired-up features of the filter-wrapper combination  
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Figure 4-5 Flowchart of the proposed framework without Pareto Optimality 
on Paired-up features of the applied filter-wrapper combination 
a) The dataset is split into test and training sets (80% training and 20% test) 
and numbers of feature dimensions are decreased in the selected feature 
pool. 
b) Cross-Validation: 𝐾 -fold (LOO, 10, 5) CV is applied to the training part 
of the datasets. 𝐾-fold preparation: Conducted to apply the SFS to the 
folds. SFS operates with an internal kNN classifier to select the relevant 
genes. 
c) SFS selects genes from each fold. After many experimental trials, we set 
the size of feature vectors to 10. 
d) For the classification task, the kNN classifier (1, 3, 5, 7, 9 NN) 
respectively is applied to test sets 20%. Classification process utilise for 
data variation because there is no PO method to combine results. 
e) Each classification provides an accuracy result. 
f) Calculated average accuracy to understand SFS methods performance 








Table 4.1 and 4.2 summarize the classification results of the three different 
datasets for the feature selection problem. Each resampling of the data is 
implemented ten times, and the mean accuracy and standard deviation along 
with corresponding feature subset sizes were obtained. In addition to the 
percentages, the different sizes of test datasets are shown in the tables. The 
methods used were evaluated for multiple Ks, but due to lack of space and for 
clarity only the results from K that yield the highest performance are presented 
here. 
Table 4.3 presents the results of the comparison of the proposed PO-based 
framework with those from previous work (Ogutcen et al., 2016). It is observed 
that the baseline methods require high numbers of features to reach maximum 
accuracy (Table 4.3) whereas the proposed approach yielded similar or higher 
accuracy rates using the same number of or fewer genes (Bolón-canedo et al., 
2014). Model-1 using all of the tests with PO shows a significant improvement 
in accuracy with the Colon dataset. This analysis gave an increase of 5% in 
predictive accuracy with around only 12 genes, which is almost 10 times lower 
than that of the previous study (Luo et al., 2011). A smaller number of genes is 
also observed for the other two datasets. The results demonstrate the robustness 
of the proposed framework, which consistently yields smaller subsets of 
features. 
Consequently, the results appear to suggest that the stability of feature selection 
in Model-1 is significantly better than that of Models 2 and 3. The stability 
seems to be similar for all the assessments and data sets. In Model-3, the 
standard deviation of different Ks in kNN is observed to be more than that of 
Model-2. Therefore, although they have similar accuracy, this model may not 
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Table 4.3: Performance comparison of Model-1 using LOO Cross-validation  
with state-of-the-art techniques using the sample subsets 












SNR (Luo et al., 2011)     84.34 10 78.20 10 81.00 20 
FFS-ACSA1 (Luo et al., 2011) 77.72 10 80.00 10 71.00 20 
FFS-ACSA2 (Luo et al., 2011) 85.09 10 78.36 10 82.83 20 
SVM-RFE   (Luo et al., 2011) 91.87 10 76.76 10 82.33 20 
Model-1 100.0±0.0 
11.60    
±4.16 
97.50      ±2.76 




24.70       
±9.95 
Sensitivity 100.0±0.0  99.50±1.12  80.67±8.59  
Specificity 100.0±0.0  93.50±8.59  86.50±15.27  
 
The selection of valid features is important in order to reduce the number of 
features in the dataset. At the same time, the models are computationally 
intensive, and so less training data provides a shorter time for feature selection. 
If training datasets of smaller sample size can provide equivalent or stronger 
results, this would improve computational efficiency. Therefore in Table 4.3, 
the performance levels of 20% test and 80% training (Luo et al., 2011) versus 
40% test and 60% training (Proposed Method Model-1) sets were compared. In 
every situation with all the models, the larger training set (80%) provided higher 
accuracy. Using a 40% test size as in (Luo et al., 2011) for low sample size 
datasets has a negative effect on overall results. When we look at the 𝐾-fold 
difference, in Models 1 and 2, LOOCV-based assessment yielded more stable 
and higher classification accuracies. In any case, the proposed framework seems 
durable and robust. 
In the second stage of the study, an experimental analysis of the proposed 
framework was carried out on both SFS+PO (Figure 4-4) and individual SFS 
(Figure 4-5) models, and the classification results for the selection problem for 
each dataset are summarised in Table 4.4-4.6. 
 Folds of the dataset is resampled and repeated for ten times, and the average 
and standard deviation of the accuracy along with the selected gene sets were 
obtained. Additionally, the performance of different test data sizes (20% and 
40%) are shown in tables 4-6. Classification performance was evaluated using 
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different values of 𝐾 but, due to limited space and for clarity, only values of 𝐾 
that yielded the best results are presented. 
As seen in Table 4.4, classification accuracy consistently reached 100% 
accuracy using SFS-PO, and the corresponding subset size depends on the 
cross-validation fold size. Furthermore, individual SFS method reached its 
maximum performance using a few numbers of genes, however its accuracy has 
remained lower than the accuracy of the proposed PO based ensemble 
framework. Moreover, SFS was not able to identify disease-related genes as 
compared to disease related-genes identified with PO based ensemble 
framework. When fold number and test set sizes were increased, the results 
included higher numbers of genes due to over-learning from the folds and 
smaller sample sizes in training. The datasets utilised included different 
versions such as with different fold sizes and varying K values. In these different 
conditions, accuracy remained robust and high. 
Table 4.4: Classification results of Colon breast cancer with the proposed 
Filter-Wrapper combined framework 
COLON Cancer  20% Test 40% Test 
  Total  acc. % Subset Size Total  acc. % Subset Size 
5-FOLD 
SFS-PO 100 ±0.0      (K=7) 15.32±2.04 94.42 ±1.58 (K=7) 10.68±1.52 
SFS         94.57 ±2.32 8 84.5 ±3.49 3 
10-FOLD 
SFS-PO 100 ±0.0    (K=7) 12.96±1.85 94.83 ±0.66 (K=7) 36.58±3.45 
SFS 88.78 ±2.71 2 90.46 ±1.62 13 
LOO 
SFS-PO 100 ±0.0     (K=5) 28.96±5.10 95.42 ±0.97 (K=7) 89.82±7.94 
SFS 91.71 ±2.42 3 91.72 ±1.10 18 
Sensitivity 100.00 ±0.0 97.63 ±0.40 





Table 4.5: Classification results of DLBCL breast cancer with the proposed 
Filter-Wrapper combined framework 
DLBCL  20% Test 40% Test 
  Total  acc. % Subset Size Total  acc. % Subset Size 
5-FOLD SFS-PO 99.38 ±1.45 (K=7) 10.94±1.64 92.06 ±4.80   (K=3) 11.40±1.54 
 SFS         92.03  ±2.89 3 86.14 ±1.91 3 
10-FOLD SFS-PO 100 ±0         (K=7) 13.44±1.66 95.16 ±4.69     (K=5) 13.16±2.02 
 SFS 90.66 ±2.20 2 86.35 ±2.16 2 
LOO SFS-PO 100 ±0       (K=9) 18.30±4.48 96.97 ±2.61  (K=5) 45.86±6.55 
 SFS 92.29 ±2.47 2 89.88 ±2.15 6 
Sensitivity 100.00 ±0.0 96.78±3.06 
Specificity 100.00 ±0.0 97.50±3.86 
 
For the DLBCL data, a relatively low number of genes is required to reach the 
highest accuracy using SFS, as seen in   
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Table 4.5. However, the best result required around 13 genes using the SFS-PO 
framework. The SFS-PO combination focuses on the overall data rather than 
just training data, and so it can achieve better accuracy in terms of disease-
related genes. PO considers each gene selected from all samples and so each 
sample has an effect on the features selected. PO evaluates each selected gene, 
and none are eliminated as in the voting methods. Therefore, PO offers a 
suitable approach for analysing cancer-related genes in microarray datasets. 
The classification performance of Duke Breast cancer data for 20% test and 
80% training versus 40% test and 60% training sets are shown in Table 4.6. 
There are very limited studies with this dataset for comparison, and it is the most 
challenging dataset of the three to maximise accuracy. The performance of the 
PO based framework was experimented with different cross-validation 
methods. Leave-one out cross validation obtained the highest accuracy for the 
Duke Breast cancer dataset as compared to 5-Fold and 10-Fold cross 
validations. However, selected subset of genes for the LOO is obtained higher 
than 5 and 10-Fold. This result may seem to contradict a common objective in 
the literature, which is to achieve maximum accuracy with a minimum subset 
size. However, PO shows its potential by including all essential genes, and this 
information can support biological studies of cancer. 
Table 4.6: Classification results of DUKE breast cancer with the proposed 
Filter-Wrapper combined framework 
DUKE Breast Cancer 20% Test 40% Test 
 Total  acc. % Subset Size Total  acc. % Subset Size 
5-FOLD SFS-PO 93.11 ±7.79    (K=7) 11.30±1.67 82.35 ±9.72      (K=3) 12.0±1.98 
 SFS         82.71 ±5.65 4 81.93 ±2.95 18 
10-FOLD SFS-PO 97.33 ±3.85   (K=7) 30.04±4.00 85.76 ±8.35    (K=5) 29.48±5.07 
 SFS 87.33 ±2.58 10 81.34 ±2.48 19 
LOO SFS-PO 98.44 ±3.88     (K=3) 90.08±10.30 88.47 ±4.65     (K=5) 67.20±9.16 
 SFS 91.39 ±1.87 19 82.23 ±1.55 20 
Sensitivity 91.20±11.19 80.67±8.59 
Specificity 100.00±0.0 86.50±15.27 
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Table 4.7: Performance comparison of ensemble methods applied to Colon 
Dataset 




















Model-1, (Ogutcen et al., 2016) 97.5 ±2.76 11.56 
±5.28 
99.50±1.12 93.50±8.59 
GBC +SVM (Alshamlan, Badr and Alohali, 2015) 98.38 - 10 - - 
MOGA (Hasnat, 2016) 82.3 ±7.2 9.03±1.6 
  
TOPSIS + SVM (Fattah et al., 2013) 88.7 - 10 - - 
 
Pareto DE (Dash and Misra, 2017) 81 - - 0.67 0.79 
Table 4.7, Table 4.9 show the results of the comparison with state-of-the-art 
ensemble methods applied to the same datasets. The first observation to note is 
the lack of information about their performance for comparison. Many of the 
comparison studies provided results only for accuracy. SFS-PO accuracy is 
better than the SFS only accuracy. This result reflects how PO integrated 
framework changes the classification accuracy using same set of methods. Only 
some of them additionally reported standard deviation without which we cannot 




Table 4.8: Performance comparison of ensemble methods applied to DLBCL 
Dataset 
 DLBCL Accuracy Sensitivity Specificity 
  Total acc. % Std. Dev. % Subset Size Acc%±Std. Acc%±Std. 
SFS-PO, 10-FOLD, 7NN 100 ±0.0 13.44 ±1.60 100.00 ±0.0 100.00±0.0 
SFS, LOO,  3NN 90.66 ±2.20 2 92.60±2.25 84.85±4.88 
Ensemble Filters-PO (Ogutcen 
et al., 2016) 
100 ±0.0 11.60 ±4.16 100.00±0.0 100.00±0.0 
EPSO (Mohamad et al., 2013) 100 ±0.0 4.7±0.82 - - 
FSAM-AHP (Nguyen et al., 
2015) 
98.70  - - - 
QMI-SVM (Mortazavi and 
Moattar, 2016) 
96.07  - - - 
 
A few of the studies provided accuracy rates for a fixed size of subset. Accuracy 
with a fixed number of genes shows how efficiently classification can be 
performed at that point. On the other hand, the proposed aggregated multi-
objective framework focuses on discovering feature dependencies in the dataset 
as a whole. 
The comparison of accuracy levels for the DLBCL data shows that EPSO is a 
competitive method (Table 8). However, EPSO is based on iteration, and so it 
continues to remove genes until maximum accuracy is reached. If the dataset 
were artificial, removing features after reaching the maximum accuracy would 
be the correct action. However, cancer datasets are not created synthetically. 
They represent the gene expression levels of real humans, and information about 
one of which may be necessary for the cancer treatment process. Thus, if any 
gene is non-dominant it should be kept in the subset for further study by 
molecular biologists. Relationships among genes are vitally important.  
Similarly, learning algorithms should not only focus on the minimum possible 
number of features. All disease-related genes should be considered when 
investigating treatment. If a gene, which is removed, has a relationship to the 
disease, this situation postpones the discovery of that gene.  Thus, the 
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methodology applied should aim to discover all disease-related genes and all 
potentially relevant genes should be considered. PO achieved better results than 
previous studies and yields different subset sizes for each cancer dataset. 
Table 4.9: Comparison of ensemble methods applied to Duke Dataset 
 DUKE Accuracy Sensitivity Specificity 






Subset Size Acc%±Std. Acc%±Std. 
SFS-PO, LOO, 3NN 98.44 ±3.88 90.08±10.30 91.20±11.19 100.00±0.0 
SFS, LOO, 3NN 91.39 ±1.87 19 89.04±3.01 94.33±2.38 
Ensemble Filters-
PO(Ogutcen et al., 2016) 
83.76 ±5.68 24.70 ±9.95 80.67±8.59 86.50±15.27 
RandEns.ReliefF (Zhou 
et al., 2014) 
91.5 - 40 - - 
LFS (Armanfard, Reilly 
and Komeili, 2016) 
89.17 ±7.90 - - - 
FFS-ACSA2 (Luo et al., 
2011) 
82.83 - 20 - - 
 
The Duke Dataset has the smallest sample number of the three datasets 
considered and this makes it much harder to gain better accuracy than in the 
studies compared in Table 7. Subset sizes start from 11 genes when 5-fold CV 
is applied and reach 90 genes when LOOCV is used. In terms of accuracy, 
differences in fold size increase accuracy levels from 93.11% to 98.44%. This 
5% increase in accuracy requires a set with an additional 81 genes. 90 genes are 
significantly more than the other two cancer dataset subset sizes. Breast cancer 
may be associated with many genes and LOO may be more suitable when a 
dataset has a small number of samples. As mentioned above, the proposed 
framework focuses on all disease-related genes in order to create meaningful 
subsets for biologists rather than just a minimum number of genes. 
Each sample influences the results.  Each fold works with one of the training set 
variations, and each training set variation contains a different group of samples. 
Dependencies among different training set samples may not be captured when 
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using voting methods. Unlike previous aggregation methods, feature 
dependencies between different folds are taken into account here in the final 
subset. This means that the results from different training set variations (which 
contain different sample sets) are considered by PO. Combining the results for 
the different cross-validation folds creates a common subset, and this provides 
a more successful classification than those in other studies (see Tables 7-9). 
Like most machine-learning algorithms, SFS aims to achieve a subset size, 
which provides maximum performance. Unlike standard machine-learning 
algorithms, PO is a multi-objective decision method, and so it evaluates all 
results together. Then, it gives all optimal solutions. A multi-objective 
technique is more suitable for the analysis of gene-expression datasets because 
of its ability to provide comprehensive information for biological studies. 
Cancer is a polygenic disease, and so if a potentially important gene is 
eliminated in the feature selection stage, the discovery of cancer-related genes 
will remain incomplete. Thus, the final subset should be optimal in the sense of 
allowing the discovery of possible disease-associated genes. 
4.7 Conclusion 
The novel framework proposed in this chapter provides promising results in 
terms of accuracy and stability over the three different benchmark microarray 
gene-expression datasets under different conditions. It was also observed that 
the ensemble of methods boosted the feature selection process, and the PO-
based approach yielded comparatively smaller feature subset sizes. 
Furthermore, in this study, a PO-based multi-objective predictive model is used 
to identify cancer-related genes in microarray data. A different set of genes was 
assessed for each cancer data set through a combination of SFS with PO. The 
proposed method outperforms SFS, and additionally the multi-objective 
framework is more effective in identifying all disease-related genes. This makes 
the final subset more representative of the whole dataset. 
In the literature, ensemble methods are mostly used for imbalanced datasets, 
and research has intensively focused on splitting methods to balance datasets. 
However, these studies either add artificial samples (oversampling) or remove 
some samples (undersampling) to achieve balance in the dataset. Next chapter 
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addresses how the proposed framework could handle the problems of data 
imbalance in gene expression datasets.  
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5 A PARETO-OPTIMAL GENE SELECTION 
FRAMEWORK FOR IMBALANCED DATA 
5.1 Introduction 
Microarray gene-expression data analysis presents a critical role for decision-
making in clinical and medical studies. However, natural datasets are mostly 
imbalance that creates a bias towards majority class when feature selection and 
classifying samples. This situation generally causes problems during the 
learning of the classifier. Among many data-level approaches commonly used 
to tackle this problem are undersampling, over-sampling and ensemble learning. 
Undersampling or oversampling may result in a loss of valuable data and 
unreliable results due to the artificially created or altered samples. 
Various datasets present more cancer cases of one class than the control samples 
of the other class in the various datasets (Shipp et al., 2002). Therefore, applying 
feature selection on imbalanced datasets requires further investigation since the 
features selected are likely to be more representative of the majority class 
(Fernandez, Garcia and Herrera, 2011). An increasing number of studies are 
being conducted on imbalanced datasets in various domains and also in 
bioinformatics (Haixiang et al., 2017).  
Gene-expression datasets have low number of samples and high numbers of 
features. Traditional classification methods are not designed for imbalanced 
situations and so classifier predictions are biased towards majority class (Ling 
and Sheng, 2010). Various solutions have been proposed in machine learning 
domain in recent years for overcoming poor prediction performance of 
classifiers on imbalanced datasets. These solutions are mainly categorised in 
data-based and algorithm-based approaches.  
A novel approach has been proposed to imbalanced microarray datasets for 
feature selection in this chapter. Since the class ratio of samples is not uniformly 
distributed, a framework is designed to handle imbalanced datasets. For this 
purpose, sub datasets that keep a balance between minority and majority classes 
were generated then combined with the imbalanced dataset. Hence, multi-
objective structure is generated with a set of balanced-sub datasets along with 
the original imbalanced dataset. Thus, the proposed framework prevented the 
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side effects of methods such as undersampling or oversampling and benefited 
from boosting the feature selection performance using supportive balanced sub-
datasets. 
5.1.1 Performance Metrics for Imbalanced Microarray Gene Expression 
Data 
The evaluation metrics (e.g., accuracy) that work well with standard balanced 
datasets might not be applicable when analysing imbalanced microarray gene-
expression data. This is due to the fact that accuracy achieved will be biased 
towards the majority class. Therefore, performance metrics other than accuracy 
should be considered in the evaluation of the classification performance of the 
proposed framework. One approach that could be used for this purpose is to find 
values of recall and precision for minority and majority classes separately using 
a confusion matrix Table 5.1 (Anaissi and Kennedy, 2011). 
Table 5.1 Confusion Matrix 
  Predicted 
  Negative Positive 
Actual 
Negative True Negative False Positive 
Positive False Negative True Positive 
 
The outcomes of the confusion matrix can be used to calculate TPR and FPR. 
Formulas are as follows (Fawcett, 2006); 
 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 = 𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑣𝑒 𝑅𝑎𝑡𝑒 (𝑇𝑃𝑅) =
𝑇𝑃
𝑇𝑃+𝐹𝑁
  Equation 5-1 
And 
       𝑅𝑒𝑐𝑎𝑙𝑙 = 𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑅𝑎𝑡𝑒 (𝑇𝑁𝑅) =  
𝑇𝑁
𝑇𝑁+𝐹𝑃
      Equation 5-2 
The F-measure (or F1 score) could also be used, which is a combination of recall 




     Equation 5-3 
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The F-measure is a better measure for imbalanced datasets than  accuracy as it 
is more capable of representing the impact of precision and recall in 
combination (Yin et al., 2013). 
5.1.2 Gene selection in imbalanced microarray datasets 
This section explains the challenges for gene selection caused by imbalanced 
data which is useful to increase the classification results in terms of f-measure 
and efficiency (Yin et al., 2013; Maldonado, Weber and Famili, 2014). Selected 
genes are supposed to improve the classification model’s ability to differentiate 
between classes. However, classifiers and feature selection methods are 
adversely affect the performs poorly when applied on imbalanced datasets.  
In many medical domains, dataset classes are not evenly distributed, and cancer 
patients represent a very small minority class, especially when the disease is 
very rare. However, most of the time, the important information to identify 
relevant genes that belongs to the minority class.   
There are two main strategies that could be used to approach the problem of 
imbalanced datasets: data-based strategy and algorithm-based strategy. For 
data-based strategy resamples the dataset in order to uniformly distribute classes 
(Chawla et al., 2003). There are two main methods used to resample the dataset 
for this purpose: undersampling and oversampling. Although some research 
studies suggest employing both of them (Anaissi and Kennedy, 2011). 
Undersampling is the removal of samples of the majority classes to match their 
size with that of the minority class. For example, SHRINC is a under sampling 
algorithm proposed by (Kubat and Matwin, 1997), to be used in reducing the 
number of majority class samples. This technique has the disadvantage of 
removing potentially useful information. Moreover, gene-expression datasets 
often have small number of samples, and in this case, undersampling is not 
suitable. Conversely, increasing the number of minority class samples is the aim 
of oversampling techniques. Minority samples are replicated so that, their 
number become equivalent to the majority class. 
Second strategy that can be used for imbalanced datasets is the algorithm-based 
approach. One main algorithm proposed for handling class imbalance is the cost 
sensitive learning (López et al., 2013). This algorithm assigns high costs to 
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misclassified samples of minority class to achieve the objective. Another well-
known strategy is the boosting approach. SMOTEBoost algorithm (Chawla et 
al., 2003), for instance, iteratively learn patterns from minority class samples 
during the training process of the classifier. 
5.2 Proposed approach for handling data imbalance 
A proposed multi-criteria approach using PO for feature selection that handles 
the microarray gene expression imbalanced datasets is presented in this section. 
In this method, the majority class is split in subsets equivalent to the size of the 
minority class. The proposed approach handled the original dataset and its 
balanced-sub datasets together. Multi-objective structure is used to match up 
balanced sub-datasets with the original dataset. 
TRAINING DATA (e.g. 80%) TEST (e.g. 20%)
Original 
Training data





















Figure 5-1 Flowchart of the proposed framework using Pareto Optimality on 




a) The dataset is split into test and training sets (80% training and 20% test) 
and numbers of feature dimensions are decreased in the selected feature 
pool. 
b) Folds are arranged in the training part to keep the balance of the classes 
(50%-50%) of the datasets. SFS applied to these balanced folds. SFS 
operates with an internal kNN classifier to select the relevant genes. 
c) SFS selects genes from each fold, and each fold forms a vector of fixed 
size features for PO. After many experimental trials, we set the size of 
feature vectors to 10. 
d) Common subset: Duplicated genes are removed from the resulting gene 
set, and a common subset is established using this unique gene content. 
e) The PO solution set is ready for classification. 
f) For the classification task, the kNN classifier (1, 3, 5, 7, 9 NN) 
respectively is applied to test sets 20%. 
As shown in Figure 5-1 proposed framework, dataset with its original 
distribution of classes is used and supported with balance-distributed sub-
datasets. Similar to the widely accepted 5-fold and 10-fold approach in the 
literature, the number of balanced datasets is chosen as ratio between each class 
data samples. During the training process, without losing any features derived 
from the original dataset, supportive features coming from the balanced sub-
datasets made an impact on the classification performance particularly for the 
minority class samples. 
Skewed class distribution has been determined a training problem in the 
literature. K-fold approach usually splits the dataset without considering 
whether it is balanced or imbalanced. In our work, the proposed sub-datasets 
are a type of replacement for the common K-fold approach specifically for the 
imbalanced datasets. Research studies on the classification of gene expression 
data widely assume the classes in the dataset are balanced and suggest ways for 
improving the classifier performance. However, as far as we know, there are not 
many studies in the bioinformatics research domain, seeking an alternative way 
of handling the problem of gene selection in imbalanced microarray gene-
expression datasets. Therefore, we proposed a PO-based approach that supports 
feature discovery to identify minority classes in a better way. According to 
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aspect ratio between classes, sub-datasets utilised with PO provides more 
comprehensive feature subsets. The proposed imbalanced dataset framework 
structure is as follows: 
• The dataset is split into test and training sets (80% training and 20% test) 
and feature dimensions decreased in the selected feature pool. 
• Training data first employed with filter methods to gain common genes 
and created a gene pool for a wrapper method. Duplicated genes are 
removed from the resulting gene set and a common subset is established 
using this unique gene content. 
• Then narrowed down dataset with the common gene pool employed with 
a wrapper method. At the same time, random subsets of major class 
samples matches with minor samples.   
• SFS is applied to the original training and balanced folds. SFS operates 
with an internal kNN classifier to select the relevant genes. 
• SFS selects genes from each fold, and each fold forms a vector of 10 
features for PO 
• The PO solution set is ready for classification. 
• For the classification task, the 𝑘NN classifier (1, 3, 5, 7 NN) is applied 
to the test sets.   
5.3 Results and Discussion 
In this section, the results of the proposed framework applied on imbalanced 
datasets were presented. Mainly, balanced datasets are important for minority 
samples classification, so they help to discover important features of the dataset 
more effectively. 
Table 5.2 Characteristics of Imbalanced Gene Expression Datasets 
  Size Features Target #Majority/#minority Ratio 
CNS 60 7129 Failures 39/21 1.86 
LYMPH 77 6817 FL 58/19 3.63 
OVARIAN 253 15154 Normal 162/91 1.78 
 
Characteristics of the applied imbalanced gene expression datasets are shown 
on Table 5.2. Three different cancer datasets in different size of samples and 
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features investigated. We studied the CNS, Lymphoma and Ovarian datasets. 
The Lymph dataset has the most imbalanced characteristics as compared the 
remaining datasets having 58 majority classes and 19 minority classes. The 
steps of the proposed multi-criteria approach using Pareto Optimality for feature 
selection are shown in Figure 5-1. 
Table 5.3 Mean and standard deviations generated for the subset-balanced 
dataset sizes and k-level of the kNN classifier at the Maximum Accuracy 
Dataset Mean Subset Size Standard Deviation of Subset Size k Level 
OVARIAN 7.59 2.45 9 
CNS 14.67 2.41 5 
LYMPH 9.31 1.91 9 
 
The mean and standard deviations of the subset-balanced dataset sizes that are 
generated and the k-level of the kNN classifier obtained at the best accuracy 
performance of our proposed framework is presented in Table 5.2. 
Table 5.4 Performance comparisons for the imbalanced CNS gene expression 
dataset 
 
F-measure for rare class F-measure for major class 
MI 0.66 0.87 
D-MI 0.70 0.85 
Fisher 0.54 0.85 
D-Fisher 0.60 0.87 
Corr 0.69 0.89 
D-Corr 0.77 0.88 
SFSPO+ 9NN 0.80 0.85 
 
In the Table 5.3 we reported the F-measure results of various methods presented 
in this research domain (Yin et al., 2013) including the proposed framework 
which are applied on imbalanced CNS gene expression dataset. Our proposed 
framework provided highest F-measure (0.80) for the minority class with a good 




Table 5.5 Performance comparisons for the imbalanced Lymph gene 
expression dataset 
 
F-measure for rare class F-measure for major class 
MI 0.65 0.86 
D-MI 0.70 0.90 
Fisher 0.54 0.85 
D-Fisher 0.59 0.87 
Corr 0.17 0.85 
D-Corr 0.32 0.87 
SFSPO+ 5NN 0.74 0.89 
 
In the Table 5.4, we reported the F-measure results of seven methods including 
the proposed framework, which are applied, on imbalanced Lymphoma gene 
expression dataset. Our proposed framework provided highest F-measure (0.74) 
for the minority class along with the second-best F-measure (0.89) for the 
majority class.  
Table 5.6 Performance comparisons for the imbalanced Ovarian gene-
expression dataset 
 
F-measure for rare class F-measure for major class 
MI 0.66 0.87 
D-MI 0.70 0.85 
Fisher 0.54 0.85 
D-Fisher 0.60 0.87 
Corr 0.59 0.91 
D-Corr 0.61 0.92 
SFSPO+9NN 0.79 0.91 
 
In the Table 5.5, we reported the F-measure results of seven methods including 
the proposed framework, which are applied, on imbalanced Ovarian gene-
expression dataset. Our proposed framework provided highest F-measure (0.74) 
for the minority class along with a second-best F-measure (0.91) for the majority 
class.  
We obtained significantly better minority class performances for the CNS, 
Lymphoma, and Ovarian gene expression datasets. Even, in the majority class, 
there is no significant difference on the performance measure. Ovarian dataset 
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has the highest number of samples, which could mitigate the effects of 
imbalanced distribution of classes. As a consequence the classifier performance 
achieved a high F-measure performance rate for both majority and minority 
class samples. In the Lymphoma dataset, interestingly we observed low F-
measures for the Corr and D-Corr methods however, their F-measures were 
better on the CNS dataset.  
Additionally, it is always preferable choosing a feature selection approach that 
proves its superiority among different dataset characteristics. In all datasets on 
which the proposed framework was applied, the remaining the methodologies 
were outperformed on the important minority class, achieving the best or 
second-best performances on the majority class. The reason for not achieving 
the best majority classification performance might be due to the fact that as the 
important genes were being added to the subset by the ensemble framework, a 
bias towards the majority class samples is inevitably occurred.  
One more interesting point we observed that performance is highly affected with 
different k-levels of the kNN classifier. The expression values of neighbour 
samples have impacts on the classifier performance. In multi-objective 
approach, different resampling of the dataset has resulted different feature 
means. Therefore, structure of the framework improved the minority class 
identification while minimising the bias effect of the majority class.  
As a result, we observed that the sample dependency is highly related with the 
performance of computational models when studying with the imbalanced gene 
expression datasets. Thus, the proposed PO based multi-objective approach has 
shown its ability in minimising such issues for the imbalance datasets. 
Moreover, since our objective is to better classify the minority class, our 
approach accomplished its objective by effectively revealing the genes having 
the most discriminative ability between the healthy and disease samples. 
5.4 Conclusion 
In this study, we have proposed a framework that selects the relevant and 
important genes particularly in imbalanced microarray gene-expression 
datasets. To the best of our knowledge, this is the first time Pareto Optimality 
is employed for gene selection in imbalanced microarray datasets. Apart from 
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the classification performance, it was shown that the proposed approach is 
capable of generating a narrow subset of genes using ensemble of feature 
selection methods.  
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6 A PARETO-OPTIMAL GENE SELECTION 
FRAMEWORK WITH MISSING VALUE 
IMPUTATION 
6.1 Introduction 
Many types of real-world experimental data often include missing values (MVs) 
(Tibshirani et al. 2001; Celton et al. 2010; Oh et al. 2011; Chiu et al. 2013) and 
microarray datasets are no exception where missing values can be found at 
different levels of gene expression profiles (Dyrskjot et al., 2003). There are 
several reasons why these experiments produce such MVs. For instance, the 
fluorescence intensity of spots may be corrupted by background signal intensity, 
fabrication faults may take place, or the microarray image might be corrupted, 
and its resolution may not be sufficient. A significant problem in microarray 
gene-expression datasets is that they often contain missing values, which can 
have adverse effects on the decision-making process (Souto et al., 2015, Wang 
et al., 2018). 
Gene expression data is now used in medical treatment, and particularly cancer 
therapeutics, more than ever before. However, this data often contains missing 
values, which should be appropriately handled before the analysis. One way to 
handle missing values is to use pre-processing methods to impute those missing 
values. 
Numerous studies have been conducted on datasets with missing values and 
how to apply imputation to them. In recent years, varieties of new imputations 
approaches have been proposed. Formerly, statistical metrics were effectively 
used in algorithms to impute missing values. 
Microarray datasets cannot be treated solely on the numerical values of gene 
expressions. They should also be considered with their biological backgrounds, 
such as gene interactions and functional importance for human life. Thus, some 
imputation methods cannot work properly with microarray data (Yang, Xu and 
Song, 2015). When samples containing MVs are eliminated from the gene 
expression dataset, the results of the classification can be biased. Discarding 
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missing values can only work for gene expression profiles that contain small 
numbers of MVs (< 5%)(Souto, Jaskowiak and Costa, 2015). 
The most basic imputation applications substitute missing values with a fixed 
number (such as zero), or finding a value from a sample very close to the sample 
containing MVs or simply replacing missing values with the mean value of the 
corresponding feature (Alizadeh et al., 2000). However, these simplistic 
approaches may lead to poor accuracy performance as they do not consider data  
correlation from the classification perspective (Troyanskaya et al., 2001). More 
advanced methods utilise feature correlations to mitigate the problem of missing 
values. These techniques include, for instance, weighted k-nearest neighbours 
(WKNN) (Troyanskaya et al., 2001), local least squares (LLS) (Kim, Golub and 
Park, 2005), and Bayesian principal component analysis (BPCA) (Oba et al., 
2003).  There is no superior imputation method that overcomes the problem of 
missing values completely. 
In recent studies, further improvements in various imputation methods have 
been achieved  (Oba et al., 2003; Wang et al., 2006; Enders, 2010; García-
Laencina, Sancho-Gómez and Figueiras-Vidal, 2010; Celton et al., 2012; Chai 
et al., 2014). The process validation usually involves a comparison of imputed 
and observed values with various performance indices (Liew, Law and Yan, 
2011). In the work of (Wang et al., 2006), three imputation algorithms, WKNN, 
LLS and BPCA, were used to impute the missing values of five different cancer 
gene-expression datasets. 
A variety of feature selection methods are used with microarray gene expression 
datasets to increase classifier performance and  prevent overfitting (Yu and Liu, 
2004; Nguyen et al., 2015; Li, Li and Yin, 2016; Mortazavi and Moattar, 2016; 
Ogutcen et al., 2016; Li, Li and Liu, 2017; Ogutcen, Belatreche and Seker, 
2018). Each method has different advantages and disadvantages, so an ensemble 
of multiple methods is discovered via Pareto Optimality. Therefore, each 
method’s benefits are combined to attain a better feature subset. 
Different imputation methods, such as using means and medians, create 
different values for the same features. However, there is no approach to combine 
and present their estimates under one solution. Imputed features are valuable as 
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they contribute to the classification, but they must be subjected to the feature 
selection process. The feature selection has been considered a standard process 
in this field, so imputed datasets were employed, and their effectiveness was 
evaluated. 
Existing studies are only applicable to gene expression profiles that are 
complete and do not consider those datasets containing missing values (Souto, 
Jaskowiak and Costa, 2015). In addition, no approach so far considers Pareto 
optimality in this context to address the modelling of microarray data with 
missing values. 
In this study, the proposed PO-based framework is used to evaluate the effect 
of imputations methods on the performance of ensemble feature selection 
methods and different classifiers. Applied framework provided promising 
results on various gene expression datasets having one or more missing gene 
values exist on their samples. 
6.2 Imputation Methods 
One of the best explanations of the precise mathematical background for 
imputing missing values can be found in Little and Rubin (Little and Rubin, 
2019). However, that work does not consider the use of machine learning 
techniques to impute the missing data. Moreover, the literature related to 
missing data imputation for microarray datasets are very limited (Troyanskaya 
et al., 2001). 
Distribution of missing values and amount of samples are effectively influences 
evaluating an imputation method, investigating the connection between 
performance of imputation methods and applicability on different datasets 
having missing values (Moorthy, Mohamad and Deris, 2014). While a variety 
of imputation techniques exist, most are local learning-based techniques which 
tend to suffer from overfitting (Wang et al., 2018). In this study, this relationship 
is investigated using the proposed Pareto optimal based multi-objective 
framework. We have implemented both statistical imputation and machine 




6.2.1 Statistical Imputation for Gene Expression 
Mean imputation: Mean imputation for gene expression replaces a single 
missing value of gene expression with the average of remaining gene 
expressions in microarray data. However, one drawback of using this method is 
that the variability (e.g., standard deviations and variance) of gene expression 
decreases which can reduce the discrimination ability of that gene (Eekhout et 
al., 2012). 
Median imputation: Median imputation for gene expression replaces a single 
missing value of gene expression with the median of remaining gene 
expressions in microarray data. This strategy is mathematically similar to 
estimating missing values with mean imputation. The median value of a gene 
of interest is simply obtained and replaced with the missing gene expressions 
found in samples. 
6.2.2 Machine Learning-based Imputation for gene expression 
Unlike basic statistical substitution methods such as mean and median based 
imputation methods, machine learning-based imputation methods are more 
complex and consider how the data is correlated (Souto, Jaskowiak and Costa, 
2015). There are variety of machine learning-based imputation methods 
available, however we have used imputation methods that are based on  k-
nearest neighbour, local least squares and Bayesian principal component 
analysis that are preferred to be studied in (Souto, Jaskowiak and Costa, 2015). 
They are particularly proposed to handle the missing values in gene-expression 
datasets and the computational complexity of them is provided in Table 6.1. In 
this table, n indicates the number of samples, p is the number of selected genes, 
k is the number of neighbours, and c is the number of components. 
These machine learning-based imputation approaches have been applied in 
numerous research studies to estimate missing values of bioinformatics related 
datasets (Souto, Jaskowiak and Costa, 2015; Choi et al., 2018; Wei et al., 2018; 
Magzoub et al., 2019). 
kNN-based imputation: kNN-based imputation is a machine learning-based 
imputation approach (Troyanskaya et al., 2001). This method finds 𝑘 neighbour 
gene expressions in samples that are closest to the gene that is of interest 
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containing missing gene expression. Each neighbour gene is weighted based on 
their similarity to the gene having the missing value. Then, kNNimpute 
algorithm replaces the missing value with weighted mean of the neighbour gene 
expressions. 
Local least squares-based imputation: Local least squares (LLS) is another 
machine learning-based imputation method that uses linear regression to 
estimate the missing gene expression (Kim, Golub and Park, 2005). Like the 
kNN approach, the LLSimpute algorithm also benefits from the nearby gene 
expressions. LLSimpute is a simple yet powerful approach and can be a better 
alternative to more used kNNimpute (Liew, Law and Yan, 2011). 
The Bayesian principal component analysis-based imputation: The 
Bayesian principal component analysis (BPCA) is a machine learning-based 
imputation method that benefits from the Bayesian methodology and a number 
of principal components for inferring the gene expression missing value (Oba 
et al., 2003). Even though BPCAimpute method is reported to be better at 
estimating missing values, its structure is relatively complex (Chai et al., 2014). 
Therefore, it is less used as compared to the well-known kNNimpute method. 
Table 6.1 The computational complexity of machine learning-based 
imputation methods used in the proposed framework 
Machine learning-based  
imputation method 
Computational Complexity 
kNN-based imputation O(npk) 
LLS-based imputation O(npk) 
BPCA-based imputation O((p + n)c + 2nc) 
  
6.3 Proposed Framework 
This section describes the proposed framework for the imputation of missing 
gene expression data. The Pareto Optimal (PO) based framework is applied to 
evaluate the effect of several imputation methods on the framework 
performance. Five different imputation techniques are applied to five different 
datasets. The imputation procedure followed is as in (Souto, Jaskowiak and 
Costa, 2015). PO selects different subsets for each dataset. Owing to feature 
selection, classification results of the proposed framework show improved 
accuracy throughout the majority of the datasets.  
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The proposed framework structure is shown in Figure 6-1; 
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TRAINING DATA (e.g. 80%) TEST (e.g. 20%)
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Ranking Method 1  Ranking Method 2 Ranking Method m
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Figure 6-1 Flowchart of the proposed framework using Pareto Optimality on 
paired-up features of Filter Methods (Model-1) applied for the datasets having 
missing values 
a) Missing values reside in the cancer datasets are imputed using both 
statistical and machine learning-based imputation methods. 
b) The dataset is divided into training and test cases and different dataset 
(20% test and 80% training or 40% test and 60% training). 
c) 𝐾-fold (5, 10 and LOO) cross-validation is applied to the training data 
sets (80% and 60%). 
d) The filter methods t-test, entropy, Bhattacharya, ROC, and Wilcoxon are 
used to rank the features. Each filter method is applied to each fold and 
ranked features are obtained. For the applied filter method, the ranked 
features of n-folds paired up. 
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e) The paired-up features from each filter test are further combined using 
PO (Figure 4-1). This will result in one subset of features. 
f) The final gene set is formed at the end of PO process. The duplicated 
genes that reside in the final gene set will then be removed. This will 
yield unique subset of a consensus gene subset.  
g) The genes that derived from the training data (consensus gene subset) 
using the PO analysis is validated using the test data. The test datasets 
(20% and 40%) are formed in two separate cases and organised using 
the consensus gene subset to validate our framework (aggregated gene 
selection using filter methods).  
h) The kNN is applied as the classification technique to evaluate our 
framework. 
In the comparison conducted by Souto et al. (2015), 5 different methods for data 
imputation were used: K-nearest neighbours (kNN), mean, median, Bayesian 
principal component analysis (BPCA), and local least squares (LSS). The 
applicability of Pareto Optimal is explored for datasets, which have missing data 
in terms of how it will improve classification performance. Different imputation 
methods create different values for genes. However, previous studies did not 
combine imputed features and neither did they apply feature selection. In the 
present study, Pareto Optimality is applied in a new way, in order to benefit 
from different set of feature selection methods. 
Previous studies (Souto, Jaskowiak and Costa, 2015) compared the distance 
calculations such as Pearson correlation, Euclidean distance, variance 
minimisation, so the most sufficiently accurate calculation is Euclidian distance 
for missing values. Therefore, the commonly used Euclidean distance metric 
was used to determine the neighbours. Nevertheless, the findings suggest that 
Euclidean distance is sensitive to outliers that can exist in microarray data  
(Troyanskaya et al., 2001).  
In this study, the imputation of varying percentage of missing values (between 
3% and 8%) of the data was investigated. One can consider the ability of the 
method to preserve the significant genes in the dataset, or its discriminatory / 
predictive power for classification or clustering purposes. The performance 
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levels of data imputation methods with a multi-criteria decision*making 
framework is compared to those found in previous studies. A Different level of 
missing data is used for comparison purposes. 
6.4 Results and Discussion 
In this section, the proposed framework is applied after the missing values have 
been imputed. Both statistical and machine learning-based imputation methods 
have been used and their impact on the performance were reported.  
The characteristics of five cancer datasets with varying percentage of missing 
values (between 3% and 8%) used in the proposed experiments is presented in 
Table 6.2. A description of the five cancer datasets, with 10% missing values, 
used in the proposed experiments is presented in Table 6.1. It shows the class 
distributions, class numbers and how many samples in classes. The proposed 
framework has used various ranking methods including t-test, Entropy, 
Bhattacharya, ROC, and Wilcoxon test and combined with PO. Also, the ratio 
of missing values that impacts the number of genes (between 40 and 75) in each 
dataset are shown in Table 6.2. Default values were applied with classifier 
settings of the linear kernel for the SVMs, kNN with k=1 and Euclidean distance 




Table 6.2 Cancer datasets with missing values 
     Original Data  






No. genes %MV %Genes 
with MV 
DLBCL Blood 2 21,21 42 4022 3.25 49.3 
Brain Brain 3 31,14,5 50 41472 7.57 43.06 
Lung Lung 4 17,40,4,5 66 24192 3.87 67.81 
Prostate Prostate 4 11,39,19,41 110 42640 4.93 67.16 
Endometrium  Endometrium 4 13,3,19,7 42 24192 7.97 74.33 
 
The proposed PO-based framework is used to assess the contribution of each 
imputation method to finding a good subset of selected genes. The performance 
of the data imputation methods with a multi-criteria decision framework with 
respect to (Souto’s, 2015) results is given in Table 6.3. 
Table 6.3 Accuracy performance comparison of various imputation methods on 
gene expression datasets using PO-based feature selection with kNN classifier. 
  






Accuracy 69.05% 92.80% 66.67% 93.20% 69.05% 91.20% 66.67% 92% 66.67% 92.40% 
Subset Size 960 32 945 29 962 32 932 23 932 25 
Brain 
Accuracy 80% 82.54% 80.00% 84.55% 80.00% 82.73% 80.00% 83.82% 80.00% 84.55% 
Subset Size 3819 65 3833 66 3825 65 3850 65 3852 66 
Lung 
Accuracy 83.33% 87.86% 83.33% 88.00% 81.82% 86.57% 83.33% 88.29% 83.33% 88.14% 
Subset Size 2563 33 2540 32 2578 36 2584 30 2603 32 
Prostate 
Accuracy 66.67% 77.39% 66.67% 75.12% 65.22% 75.56% 66.67% 77.22% 63.77% 77.04% 
Subset Size 3846 34 3811 35 3833 32 3838 37 3930 39 
Endometrium 
Accuracy 80.95% 82.87% 76.19% 85.18% 76.19% 85.17% 76.19% 84.72% 76.19% 84.26% 
Subset Size 942 51 2074 69 2078 65 2073 63 2073 63 
 
The obtained results show that the proposed framework provided higher 
accuracy for the microarray imputed gene expression datasets. Real-world 
datasets often contain missing values and simple removal of samples involving 
missing values can cause overfitting of the trained model to the dataset or bias 
toward the classes of samples that do not contain any missing value. However, 
the obtained results clearly show how important finding unique subsets 
representing genes with imputed missing values on gene expression datasets 
reflecting a realistic real-world solution. 
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Table 6.4 Accuracy performance comparison of various imputation methods on 
gene expression datasets using PO-based feature selection with SVM classifier. 
 
 







Accuracy 91.48% 93.60% 91.48% 93.60% 88.10% 92.00% 91.48% 93.20% 91.48% 92.40% 
Subset Size 960 32 945 28 962 32 932 23 932 25 
Brain 
Accuracy 84.00% 95.44% 84.00% 95.45% 84.00% 95.45% 84.00% 95.45% 84.00% 95.45% 
Subset Size 3819 65 3819 66 3819 65 3819 65 3819 66 
Lung 
Accuracy 81.82% 94.99% 81.82% 94.29% 80.30% 93.57% 83.33% 92.86% 83.33% 93.57% 
Subset Size 2563 33 2563 32 2563 36 2563 30 2563 32 
Prostate 
Accuracy 82.61% 95.65% 84.06% 95.00% 79.71% 95.65% 82.61% 96.52% 81.16% 96.52% 
Subset Size 3846 34 3846 32 3846 32 3846 37 3846 39 
Endometrium 
Accuracy 79.57% 89.81% 80.95% 90.74% 80.95% 91.20% 78.57% 90.74% 80.95% 90.28% 
Subset Size 942 51 942 63 942 64 942 62 942 63 
 
Each gene expression dataset has its natural content and causes a different level 
of accuracy and subset sizes. The proposed method obtained a high accuracy 
classification performance on DLBCL-Blood dataset for each of the imputation 
method that is employed. This shows that dominant features of that dataset were 
successfully identified. kNN-PO resulted in the best classification performance 
(93.2%) for this dataset. However, we observed that our work accomplishes 
very close outcomes for each of the imputation method we studied. Likewise, a 
drastic increase in accuracy is observed for the Prostate dataset, the kNN-PO 
yielded the best classification performance reaching 98.26%. It should be noted 
that, the main similarity here is that both of these datasets include binary class 
data. 
The applied framework is provided better performance with two of the 
multiclass datasets. Increases in performance are observed between 2% to 5% 
on accuracy. However, for the Endometrium dataset accuracy performance is 
slightly lower than the previous study.  
It is observed that the different imputation methods could not easily be separated 
in terms of accuracy. There is no clear distinction for the best imputation method 
to generalise for imputation technique. When we change the classifier, the 
highest accuracies changed, occasionally switching to a different imputation 
method. In addition, regardless of which imputation method was used, feature 
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subsets of similar size were chosen. These shows that the recovery of missing 
data with different imputation methods do not provide a significant benefit 
among themselves. But we still consider that the difference in classifier 
performance highly dependent on variance of the gene expressions. The main 
benefit of our PO-based study is its ability to narrow down the genes from a 
thousand of genes. Moreover, these genes might more likely related to samples 
having the disease As seen in Table 6.3, accuracy values for the DLBCL(Blood) 
and Prostate datasets are increased dramatically. This can provide a baseline for 
further studies. 
Missing values in datasets is challenging and it is hard to gain maximum 
accuracy because recovering missing values is limited to the number of other 
samples and general structure of the dataset. 
The results reported in this chapter provided improvements in 4 out of 5 the 
dataset considered. In two datasets, namely DLBCL(Blood) and Prostate, a 
significant improvement in results were achieved. Of the remaining two 
datasets, the results from the proposed framework for Brain and Lung showed 
3% to 5% higher accuracy respectively. Only for the Endometrium dataset was 
accuracy slightly lower than in the previous study.  
The Endometrium dataset was a challenging dataset with a huge number of 
genes however only a small number of samples utilizing such a gene set. It has 
42 samples and 24,192 genes. In this case, multi-criteria feature selection could 
not improve the results.  
6.5 Conclusion 
The impact of common imputation methods on feature selection for different 
classification methods with PO-based framework has been analysed and their 
performance accuracy is compared against existing related works (Souto, 
Jaskowiak and Costa, 2015). There are not many studies that evaluate the 
contributions of imputation methods on ensemble methods. The experimental 
evaluation showed that the proposed framework based on ensemble feature 
selection methods performed reasonably well on datasets with missing values 
using different data imputation methods to recover missing gene information. 
Moreover, the outcome of this study provides a perspective on how imputation 
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methods affect different disease-related gene expression datasets and the 
performance of different classifiers combined with ensemble feature selection 
methods.   
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7 CONCLUSION AND FUTURE WORK 
7.1 Thesis Summary 
This thesis proposed, for the first time, a Pareto optimal based gene selection 
framework for biomarker discovery in microarray datasets. The proposed 
framework aims to identify a subset of disease relevant genes in microarray 
datasets. The framework integrates different filter methods combined with 
cross-validation and various classification approaches.  A PO method was used 
to combine the results of multiple learning methods to represent the data from 
different perspectives. While the proposed framework has been thoroughly 
evaluated on various well-known microarray datasets, its applicability can be 
further extended to other datasets, which contain a low number of high-
dimensional samples. The experimental results have shown that the proposed 
framework can achieve comparable or higher predictive accuracy with 
relatively fewer features.  
Another problem in representative gene selection is the dependency on the 
employed feature selection method where different filtering methods can 
achieve different subsets of genes. The use of PO method again proved to 
provide a viable solution to this problem and was able to select relevant subsets 
of genes. 
Class imbalance is one of the challenging problems in data classification and 
bioinformatics datasets are no exception.  The ability of the proposed 
framework to handle imbalanced microarray datasets was explored. It was 
shown that the proposed PO based framework can leverage the power of 
combining various data sampling methods in order to select optimal subsets of 
genes that are less biased towards the majority class.  
Missing data is another crucial problem that was considered by the proposed 
framework given that microarray gene-expression datasets often contain 
missing values, which can result in a biased gene classification. The ability of 
the proposed framework to benefit from common data imputation methods was 
investigated in this thesis. The effect of common imputation methods on the 
performance of the proposed Pareto optimal based gene selection framework 
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was been analysed. The obtained results showed that the proposed framework 
can cope reasonably well with datasets presenting missing values. 
7.2 Summary of Core Contributions 
7.2.1 Pareto Optimal Framework for Feature Selection on Biological 
Data Sets 
The primary contribution of this thesis is a new Pareto Optimal framework to 
select a subset of genes from microarray gene-expression datasets. The 
dependencies of the selection process were observed on a sample dataset. The 
results showed that even in almost identical subsets formed by excluding one 
sample of the entire dataset and including the other, attribute selection methods 
could produce different selections. The experiments showed that the results 
obtained with a single method or a single training set are unreliable because 
different data sets and different methods select different attributes. In order to 
find solutions to this problem, multi-criteria approaches have been proposed to 
improve the feature selection methods. The proposed methods have been 
applied to different biological data sets. 
An aggregated cross-validation PO framework combined different filter 
methods, t-test, entropy, Wilcoxon, ROC, and Bhattacharya. Moreover, 
different data variations combined with SFS that is a wrapper method. This 
framework is applied to three different data conditions. As a result, it has been 
shown that the PO-based hybrid approach, which combines local experts in 
multi-criteria decision-making, can be used to select the genes most relevant to 
various cancer diseases. In addition, PO minimized dependence on data set 
diversity using multiple criteria to select genes. Furthermore, when selecting the 
most successful gene subset, the number of subsets was determined by the 
method when the PO did not need parameters such as the number of elements 
to be selected or the selection threshold. Applying PO with a combination of 
different methods increases the success of attribute selection methods.  
The results in three studies with multiple datasets demonstrate the benefit of 
ensemble framework with on multi-objective method, namely PO. Progressive 
improvement on the subsets of each dataset provided higher accuracy than 
previous studies and narrowed down subsets for further biological studies. 
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7.2.2 Gene Selection on Imbalanced Datasets  
The proposed multi-criterion mixing method was applied to the imbalanced data 
set. Again, the dependence on data set variation was minimized by using 
multiple learning sets with PO method. In addition, it is aimed to reduce the 
method dependence of the feature selection process by using a combination set 
of 5 different methods. Moreover, natural distribution, balanced distribution and 
support method has been reached with more inclusive gene clusters. Better 
recognition of the minority class by the genes we selected confirms our results. 
The results show that additionally selected genes are useful in identifying the 
minority class. 
Then imbalanced classes supported by balanced subsets and gained higher 
discriminative genes and bring some noise for majority class identification. 
7.2.3 Gene Selection on Datasets Having Missing Values 
Imputation methods compared for feature selection on the PO-based 
framework. Effectiveness of each method has been measured. 𝑘-NN based 
imputation presented a slightly better contribution to features selection for 
classification. 
7.3 Future Research Directions 
The successful integration of local methods with multi-criteria decision-making 
methods suggests that local attribute selection methods can also be combined to 
further optimise both the size and relevance of the selected subsets of the genes. 
This possibility can be considered as a future extension of the proposed 
framework.  
In microarray data, the proposed hybrid method can also be used to reduce the 
relatively large number of genes selected by conventional microarray methods. 
The applicability of the proposed framework can be further extended to other 
microarray analysis applications such as predictive modelling of gene 
expression, gene sequencing and building genomic diagnostic tools.   
For imbalanced classes, PO based framework can adjust learning difference as 
inverse class ratio, that means making the minority class as majority class for 
sub-dataset when dataset has enough sample size for the minority class. 
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Following the promising results of this study, future work could investigate the 
impact of different PO thresholds and consider the different levels of dominated 
features to boost accuracy for different datasets. Also, the efficiency of various 
combinations of filter methods and classifier models can be further explored 
using the proposed framework. 
Finally, the prioritisation of genes is another critical issue. The analytical 
hierarchy process could be integrated into to the proposed framework, which 
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